Giovanni Martinotti

Pubblicazioni Scientifiche:  Peer Review Journals con Impact Factor

N°: 408

H-Index: 71

Citazioni (totali): 15326

Impact Factor (totale): 1831

1)    D'Ascenzo M, Martinotti G, Azzena GB, Grassi C.cGMP/protein kinase G-dependent inhibition of N-type Ca2+ channels induced by nitric oxide in human neuroblastoma IMR32 cells. Journal of Neuroscience  Sep 1;22(17):7485-92, 2002

2)    Schifano F, Leoni M, Martinotti G, Rawaf S, Rovetto F.Importance of cyberspace for the assessment of the drug abuse market: preliminary results from the Psychonaut 2002 project. Cyberpsychology and  Behaviour Aug;6(4):405-10, 2003

3)    Schifano F, Oyefeso A, Corkery J, Cobain K, Jambert-Gray R, Martinotti G, Ghodse AH. Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002. Human Psychopharmacology: Clinical and Experimental Oct;18(7):519-24, 2003

4)    Grassi C, D'Ascenzo M, Torsello A, Martinotti G, Wolf F, Cittadini A, Azzena GB.Effects of 50 Hz electromagnetic fields onvoltage-gated Ca2+ channels and their role in modulation of neuroendocrine cell proliferation and death. Cell Calcium  Apr;35(4):307-15, 2004

5)    Janiri L, Martinotti G, Dario T, Reina D, Paparello F, Pozzi G, Addolorato G, Di Giannantonio M, De Risio S. Anhedonia and substance-related symptoms in detoxified drug dependent subjects: a correlation study. Neuropsychobiology 52(1): 37-44, 2005

6)    Grimaldi L, De Giorgio F, Masullo M, Zoccai GB, Martinotti G, Rainio J. Suicide by pencil. Journal of Forensic Science 50(4):913-4, 2005

7)    Schifano F, Deluca P, Agosti L, Martinotti G, Corkery JM, Alex B, Caterina B, Heikki B, Raffaella B, Anna C, Lucia DF, Dorte DR, Magi F, Susana F, Irene F, Claude G, Lisbet H, Lene SJ, Mauro L, Christopher L, Aino M, Teuvo P, Milena P, Salman R, Damien R, Angela RM, Francesco R, Norbert S, Holger S, Josep T, Marta T, Francesco Z; Psychonaut 2002 Research Group. New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic'). Journal of Psychopharmacology 19(6):675-9, 2005

8)    Martinotti G, Andreoli S, Giametta M , Poli V , Bria P , Janiri L. The dimensional assessment of personality in pathological and social gamblers: the role of Novelty Seeking and Self-Transcendence. Comprhensive Psychiatry, 47(5):350-6, 2006

9)    Janiri L, Martinotti G, Dario T, Schifano F, Bria P. The gamblers’ temperament and character inventory (TCI) personality profile. Substance Use and Misuse 42(6):975-84, 2007

10)    Martinotti G, Romanelli R, Di Nicola M, Reina D, Janiri L. Oxcarbazepine at high dosages for the treatment of alcohol dependence. American Journal on Addictions, 16(3):247-8, 2007

11)    Martinotti G, Di Nicola M, Janiri L. Efficacy and safety of aripiprazole in alcohol dependence.  American Journal on Drug and Alcohol Abuse, 33(3):393-401, 2007

12)    Martinotti G, Di Nicola M, Romanelli R, Andreoli S, Pozzi G, Moroni N, Janiri L. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients. Human Psychopharmacology: Clinical and Experimental, 22(3):149-56, 2007

13)    Rusch N, Spoletini I, Wilke M, Bria P, Di Paola M, Di Iulio F, Martinotti G, Caltagirone C, Spalletta G.Prefrontal-thalamic-cerebellar gray matter networks and executive functioning in schizophrenia. Schizophrenia Research 93(1-3): 79-89, 2007

14)    Mazza M, Di Nicola M, Martinotti G, Taranto C, Pozzi G, Conte G, Janiri L, Bria P, Mazza S. Oxcarbazepine in bipolar disorder: a critical review of the literature. Expert Opinion on Pharmacotherapy  8(5):649-56, 2007

15)    Mazza M, Della Marca G, Di Nicola M, Martinotti G, Pozzi G, Janiri L, Bria P, Mazza S.Oxcarbazepine improves mood in patients with epilepsy. Epilepsy and Behaviour 10(3):397-401, 2007

16)    Janiri L, Martinotti G, Di Nicola M. Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: results from a pilot study. Journal of Clinical Psychopharmacology 27(5):519-20, 2007

17)    Martinotti G, Di Nicola M, Reina D, Andreoli S, Focà F, Cunniff A, Tonioni F, Bria P Janiri L. Alcohol protracted withdrawal syndrome: the role of anhedonia. Substance Use and Misuse 43(3):271-84, 2008

18)    Pozzi G, Martinotti G, Reina D, Dario T, Frustaci A, Janiri L, Bria P. Post-detoxification anhedonia: influence of clinical and psychosocial characteristics. Substance Use and Misuse 43(5):722-32, 2008

19)    Martinotti G, Cloninger CR, Janiri L. Temperament and character inventory dimensions and anhedonia in detoxified substance-dependent subjects. American Journal on Drug and Alcohol Abuse, 34(2):177-83, 2008

20)    Martinotti G, Andreoli S, Di Nicola M, Di Giannantonio M, Sarchiapone M, Janiri L. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics. Human Psychopharmacology: Clinical and Experimental 23: 1–8, 2008

21)    Martinotti G, Di Nicola M, Tedeschi D, Mazza M, Janiri L, Bria P. Efficacy and safety of pregabalin in alcohol dependence. Advances in Therapy 25(6):608-18, 2008

22)    Marini A, Spoletini I, Rubino IA, Ciuffa M, Bria P, Martinotti G, Banfi G, Boccascino R, Strom P, Siracusano A, Caltagirone C, Spalletta G.The language of schizophrenia: An analysis of micro and macrolinguistic abilities and their neuropsychological correlates. Schizophrenia Research, 2008 Oct;105(1-3):144-55.

23)    Martinotti G, Mandelli L, Di Nicola M, Serretti A, Fossati A, Borroni S, Cloninger CR, Janiri L. Psychometric characteristic of the Italian version of the Temperament and Character Inventory--revised, personality, psychopathology, and attachment styles. Comprehensive Psychiatry, 2008 Sep-Oct;49(5):514-22.

24)    Rusch N, Spoletini I, Wilke M, Martinotti G, Bria P, Trequattrini A, Bonaviri G, Caltagirone C, Spalletta G. Inferior frontal white matter volume and suicidality in schizophrenia. Psychiatry Research, 2008 Dec 30;164(3):206-14

25)    Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V, Tedeschi D, Martinotti G, Colombo R, Bria P, Serretti A, Janiri L. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up. Journal Affective Disorders, 2009 May;115(1-2):27-35.

26)    Martinotti G, Di Nicola M, Di Giannantonio M, Janiri L. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. Naltrexone. Journal Psychopharmacology, 2009 Mar;23(2):123-9.

27)    Janiri L, Martinotti G, Tonioni F, Ghelardini C, Galeotti N, Nicolai R, Mosconi L, Calvani M, Bartolini A.  Acetyl-L-carnitine in the management of pain during methadone withdrawal syndrome. Neuropsychopharmacology, 2009 Jan-Feb;32(1):35-40.

28)    Spoletini I, Cherubini A, Di Paola M, Banfi G, Rüsch N, Martinotti G, Bria P, Rubino IA, Siracusano A, Caltagirone C, Spalletta G. Reduced fronto-temporal connectivity is associated with frontal gray matter density reduction and neuropsychological deficit in schizophrenia. Schizophrenia Research, 2009 Mar;108(1-3):57-68.

29)    Martinotti G, Di Nicola M, Tedeschi D, Cundari S, Janiri L. Empathy ability is impaired in alcohol-dependent patients. American journal on Addictions, 2009 Mar-Apr;18(2):157-61

30)    Martinotti G, Di Nicola M, Andreoli S, Mazza M, Pomponi M, Tedeschi D, Romanelli R, Moroni N, Pozzi G, Bria P, Janiri L. Pregabalin versus Naltrexone in alcohol dependence: a randomised, double-blind, comparison trial. Journal  Psychopharmacology, 2010 Sep;24(9):1367-74

31)    Mandelli L, Mazza M, Martinotti G, Di Nicola M, Daniela T, Colombo E, Missaglia S, De Ronchi D, Colombo R, Janiri L, Serretti A. Journal Affective Disorders, 2009 Dec;119(1-3):205-9.

32)    Tonioni F, Martinotti G, Barra A, Martinelli D, Autullo G, Rinaldi C, Tedeschi D, Janiri L, Bria P.  Cocaine use disorders and serum magnesium profile. Neuropsychobiology, 2009;59(3):159-64.

33)    Martinotti G, Carli V, Tedeschi D, Di Giannantonio M, Roy A, Janiri L, Sarchiapone M. Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses. Additive Behaviors, 2009 Sep;34(9):790-3

34)    Angelucci F, Ricci V, Martinotti G, Caltagirone C, Bria P. Paliperidone for treatment of obsessive compulsive resistant symptoms in schizophrenia: a case report. Progress Neuropsychopharmacology and Biological Psychiatry. 2009 Oct 1;33(7):1277-8.

35)    Martinotti G, di Nicola M, Frustaci A, Romanelli R, Tedeschi D, Guglielmo R, Guerriero L, Bruschi A, De Filippis R, Pozzi G, Di Giannantonio M, Bria P, Janiri L. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison tria. Addiction. 2010 Feb;105(2):288-99.

36)    Di Nicola M, Tedeschi D, Mazza M, Martinotti G, Harnic D, Catalano V, Bruschi A, Pozzi G, Bria P, Janiri L. Behavioural addictions in bipolar disorder patients: Role of impulsivity and personality dimensions. Journal Affective Disorders. 2010 Jan 16. [Epub ahead of print]

37)    Mandelli L, Mazza M, Martinotti G, Tavian D, Colombo E, Missaglia S, Di Nicola M, De Ronchi D, Negri G, Colombo R, Janiri L, Serretti A. Further evidence supporting the influence of brain-derived neurotrophic factor on the outcome of bipolar depression: independent effect of brain-derived neurotrophic factor and harm avoidance. Journal Psychopharmacology. 2010 Feb 8. [Epub ahead of print]

38)    Di Nicola M, Martinotti G, Mazza M, Tedeschi D, Pozzi G, Janiri L. Quetiapine as add-on treatment for bipolar I disorder with comorbid compulsive buying and physical exercise addiction. Progress Neuropsychopharmacology and Biological Psychiatry. 2010 May 30;34(4):713-4. Epub 2010 Mar 16

39)    Di Nicola M, Martinotti G, Tedeschi D, Frustaci A, Mazza M, Sarchiapone M, Pozzi G, Bria P, Janiri L. Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome. Human Psychopharmacology. 2010 Apr;25(3):268-75.

40)    Mazza M, Mandelli L, Martinotti G, Di Nicola M, Tavian D, Negri G, Colombo E, Missaglia S, De Ronchi D, Colombo R, Janiri L, Serretti A. Further evidence supporting the association between 5HTR2C gene and bipolar disorder. Psychiatry Research. 2010 May 20. [Epub ahead of print]

41)    Angelucci F, Ricci V, Martinotti G, Palladino I, Spalletta G, Caltagirone C, Bria P. Ecstasy (MDMA)-addicted subjects show increased serum levels of brain-derived neurotrophic factor, independently from a rise of drug-induced psychotic symptoms. Addiction Biology.2010 May 11. [Epub ahead of print]

42)    Spalletta G, Morris DW, Angelucci F, Rubino IA, Spoletini I, Bria P, Martinotti G, Siracusano A, Bonaviri G, Bernardini S, Caltagirone C, Bossù P, Donohoe G, Gill M, Corvin AP. BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia. European Psychiatry. 2010 Apr 27. [Epub ahead of print]

43)    Mazza M, Mandelli L, Martinotti G, Di Nicola M, Tavian D, Negri G, Colombo E, Missaglia S, De Ronchi D, Colombo R, Janiri L, Serretti A. Further evidence supporting the association between 5HTR2C gene and bipolar disorder. Psychiatry Research 2010 May 20. [Epub ahead of print]

44)    Villella C, Martinotti G, Di Nicola M, Cassano M, La Torre G, Gliubizzi MD, Messeri I, Petruccelli F, Bria P, Janiri L, Conte G. Behavioural Addictions in Adolescents and Young Adults: Results from a Prevalence Study. Journal Gambling Studies. 2010 Jun 18. [Epub ahead of print]

45)    Martinotti G, Reina D, Di Nicola M, Andreoli S, Tedeschi D, Ortolani I, Pozzi G, Iannoni E, D'Iddio S, Janiri L. Acetyl-L-Carnitine for Alcohol Craving and Relapse Prevention in Anhedonic Alcoholics: A Randomized, Double-Blind, Placebo-Controlled Pilot Trial. Alcohol Alcoholism. 2010 Jun 30. [Epub ahead of print]

46)    Spoletini I, Piras F, Fagioli S, Rubino IA, Martinotti G, Siracusano A, Caltagirone C, Spalletta G. Suicidal attempts and increased right amygdala volume in schizophrenia. Schizophrenia Research. 2010 Sep 23. [Epub ahead of print]

47)    De Berardis D, Di Iorio G, Acciavatti T, Conti C, Serroni N, Olivieri L, Cavuto M, Martinotti G, Janiri L, Saverio F, Pio Conti M, Di Giannantonio M. The Emerging Role of Melatonin Agonists in the Treatment of Major Depression: Focus on Agomelatine. CNS Neurological Disorders: Drug Targets. 2010 Sep 29. [Epub ahead of print]

48)    Ricci V, Pomponi M, Martinotti G, Bentivoglio A, Loria G, Bernardini S, Caltagirone C, Bria P, Angelucci F.  Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in Parkinson disease patients.  Journal Clinical Psychopharmacology.2010 Dec;30(6):751-3.

49)    Ricci V, Martinotti G, Gelfo F, Tonioni F, Caltagirone C, Bria P, Angelucci F. Chronic ketamine use increases serum levels of brain-derived neurotrophic factor. Psychopharmacology (Berl). 2010 Dec 14. [Epub ahead of print]

50)    Martinotti G, Ricci V, Di Nicola M, Caltagirone C, Bria P, Angelucci F. Brain-Derived Neurotrophic Factor and Electroconvulsive Therapy in a Schizophrenic Patient With Treatment-Resistant Paranoid-Hallucinatory Symptoms. Journal ECT. 2011 Jan 4. [Epub ahead of print]

51)    Martinotti G, Andreoli S, Reina D, Di Nicola M, Ortolani I, Tedeschi D, Fanella F, Pozzi G, Iannoni E, D'Iddio S, Janiri.L. Acetyl-L-Carnitine in the treatment of anhedonia, melancholic and negative symptoms in alcohol dependent subjects. Progress Neuropsychopharmacol Biol Psychiatry. 2011 Jan 19. [Epub ahead of print]

52)    Martinotti G, Di Iorio G, Tedeschi D, De Berardis D, Niolu C, Janiri L, Di Giannantonio M. Prevalence and intensity of basic symptoms among cannabis users: an observational study. American Journal on Drug and Alcohol Abuse, 2011 Mar;37(2):111-6

53)    Di Giannantonio M, Di Iorio G, Guglielmo R, De Berardis D, Conti CM, Acciavatti T, Cornelio M, Martinotti G. Major depressive disorder, anhedonia and agomelatine: an open-label study Journal Biological Regulators Homeostatic Agents. 2011 Jan-Mar;25(1):109-14.

54)    Addolorato G, Leggio L, Ferrulli A, Cardone S, Bedogni G, Caputo F, Gasbarrini G, Landolfi R; the Baclofen Study Group. Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of A Randomized, Double-Blind, Placebo-Controlled Trial. Alcohol Alcoholism  2011 Mar 17. [Epub ahead of print]

55)    Angelucci F, Martinotti G, Gelfo F, Righino E, Conte G, Caltagirone C, Bria P, Ricci V. Enhanced BDNF serum levels in patients with severe pathological gambling. Addiction Biology. 2011 Nov 1[Epub ahead of print]

56)    Di Nicola M, Tedeschi D, Martinotti G, De Vita O, Monetta M, Pozzi G, Janiri L. Pregabalin augmentation in treatment-resistant obsessive-compulsive disorder:a 16-week case series. Journal Clinical Psychopharmacology. 2011 Oct;31(5):675-7

57)    Picardi A, Martinotti G, Paci M, Simi C, Caroppo E. Reliability of self-reported attachment style in patients with severe psychopathology. Journal Personality Assessment. 2011 Sep-Oct;93(5):491-9.

58)    Mazza M, Mandelli L, Zaninotto L, Nicola MD, Martinotti G, Harnic D, Bruschi A, Catalano V, Tedeschi D, Colombo R, Bria P, Serretti A, Janiri L. Factors associated with the course of symptoms in bipolar disorder during a 1-year follow-up: Depression vs. sub-threshold mixed state. Nordic Journal of Psychiatry. 2011 Dec;65(6):419-26. Epub 2011 Jul 5

59)    Catalano V, Harnic D, Di Nicola M, Mazza M, Martinotti G, Bruschi A, Di Felice C, Carnevale E, Marano G, Pozzi G, Bria P, Janiri L. Diagnosis of deficit and attention/hyperactivity disorders (ADHD) in patients with bipolar or unipolar depression: an experimental study. Clinica terapeutica2011 Mar-Apr;162(2):107-11.

60)    Mazza M, Di Nicola M, Catalano V, Callea A, Martinotti G, Harnic D, Bruschi A, Battaglia C, Janiri L. Description and validation of a questionnaire for the detection of meteoropathy and meteorosensitivity: the METEO-Q. Comprehensive Psychiatry. 2011 Apr 11

61)    Cinosi E, Di Iorio G, Acciavatti T, Cornelio M, Vellante F, De Risio L, Martinotti G. Sleep disturbances in eating disorders: a review. Clin Ter. 2011 Nov;162(6):e195-202.

62)    Carano A, De Berardis D, Campanella D, Serroni N, Ferri F, Di Iorio G, Acciavatti T, Mancini L, Mariani G, Martinotti G, Moschetta FS, Di GiannantonioM. Alexithymia and suicide ideation in a sample of patients with binge eating disorder. J Psychiatr Pract. 2012 Jan;18(1):5-11.

63)    Guglielmo R, Martinotti G, Janiri L. Gabapentin as add-on treatment for somatoform disorder: a case report. Clin Neuropharmacol. 2012 Jan;35(1):45-6.

64)    De Berardis D, Serroni N, Campanella D, Olivieri L, Ferri F, Carano A, CavutoM, Martinotti G, Cicconetti A, Piersanti M, Saverio Moschetta F, Di Giannantonio M. Update On The Adverse Effects Of Clozapine: Focus On Myocarditis. Current Drug Safety. 2012 Feb 1;7(1):55-62.

65)    Innamorati M, Pompili M, Martinotti G, Serafini G, Amore M, Lester D, Girardi P, Janiri L. Trends In Alcohol-Related Deaths In The EU Countries In 1980-2003. International Journal Social Psychiatry. 2012 Apr 16. [Epub Ahead Of Print] Pubmed PMID: 22508718.

66)    Schifano F, Martinotti G, Cunniff A, Reissner V, Scherbaum N, Ghodse H. Impact Of An 18-Month, NHS-Based, Treatment Exposure For Heroin Dependence: Results From The London Area Treat 2000 Study. American Journal Addiction. 2012 May-Jun;21(3):268-73.Epub 2012 Mar 30.

67)    Picardi A, Caroppo E, Porcelli P, Di Maria G, Munittola G, Martinotti G. Alexithymia And Severe Psychopathology: A Study On Psychiatric Inpatients. Psychopathology. 2012;45(3):159-66. Epub 2012 Mar 2.

68)    Mandelli L, Mazza M, Di Nicola M, Zaninotto L, Harnic D, Catalano V, Tedeschi  D, Martinotti G, Bria P, Janiri L, Serretti A. Role Of Substance Abuse Comorbidity And Personality On The Outcome Of Depression In Bipolar Disorder: Harm Avoidance Influences Medium-Term Treatment Outcome. Psychopathology. 2012;45(3):174-8

69)    Martinotti G, Sepede G, Gambi F, Di Iorio G, Di Nicola M, Onofry M, Janiri L, Di Giannantonio M. Agomelatine Vs. Venlafaxine For The Treatment Of Anhedonia In Major Depressive Disorder. Journal Clinical Psychopharmacology. In Press

70)    Pomponi M, Janiri L, La Torre G, Di Stasio E, Di Nicola M, Mazza M, Martinotti G, Bria P, Lippa S, Natili R, Pomponi MF. Plasma Levels Of N-3 Fatty Acids In Bipolar Patients: Deficit Restricted To DHA. Journal of Psychiatric Research, Vol. 47

71)    Di Paola M, Luders E, Rubino IA, Siracusano A, Manfredi G, Girardi P, Martinotti G., Thompson PM, Chou YY, Toga AW, Caltagirone C, Spalletta G. (2012). The Structure Of The Corpus Callosum In Obsessive Compulsive Disorder. European Psychiatry, Vol. 27

72)    Martinotti G. Pregabalin In Clinical Psychiatry And Addiction: Pros And Cons. Expert Opinion on Investigational Drugs. 2012 Sep;21(9):1243-5.

73)    Martinotti G., DS. Hatzigiakoumis, O. De Vita, M. Clerici, F. Petruccelli, M. Di Giannantonio, L. Janiri.  Anhedonia and reward system: psychobiology, evaluation, and clinical features. International Journal of Clinical Medicine. (3) 2013

74)    Pettorruso M, Martinotti G, Di Nicola M, Onofrj M, Di Giannantonio M, Conte G, Janiri L. Amantadine in the treatment of pathological gambling: a case report. Front Psychiatry. 2012;3:102

75)    Guglielmo R, Martinotti G, Clerici M, Janiri L. Pregabalin for alcohol dependence: a critical review of the literature. Adv Ther. 2012 Nov;29(11):947-57

76)    Di Nicola M, De Risio L, Battaglia C, Camardese G, Tedeschi D, Mazza M, Martinotti G, Pozzi G, Niolu C, Di Giannantonio M, Siracusano A, Janiri L. Reduced hedonic capacity in euthymic bipolar subjects: A trait-like feature? J Affect Disord. 2012 Oct 31

77)    Mazza M, Mandelli L, Zaninotto L, Nicola MD, Martinotti G, Harnic D, Bruschi A, Catalano V, Tedeschi D, Colombo R, Bria P, Serretti A, Janiri L. Bipolar disorder: "pure" versus mixed depression over a 1-year follow-up. Int J Psychiatry Clin Pract. 2012 Jun;16(2):113-20

78)    Martinotti G, Lupi M, Sarchione F, Santacroce R, Salone A, De Berardis D,Serroni N, Cavuto M, Signorelli M, Aguglia E, Valchera A, Iasevoli F, DiGiannantonio M. The potential of pregabalin in neurology, psychiatry andaddiction: a qualitative overview. Curr Pharm Des. 2013 Jun 14.

79)    Di Iorio G, Matarazzo I, Di Tizio L, Martinotti G. Treatment-resistantinsomnia treated with pregabalin. Eur Rev Med Pharmacol Sci. 2013Jun;17(11):1552-4. PubMed PMID: 23771546.

80)    De Berardis D, Marini S, Serroni N, Rapini G, Iasevoli F, Valchera A, Signorelli M, Aguglia E, Perna G, Salone A, Di Iorio G, Martinotti G, Di Giannantonio M. S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study. Scientific World Journal. 2013 May

81)    De Berardis D, Marini S, Fornaro M, Srinivasan V, Iasevoli F, Tomasetti C, Valchera A, Perna G, Quera-Salva MA, Martinotti G, di Giannantonio M. The melatonergic system in mood and anxiety disorders and the role of agomelatine:implications for clinical practice. Int J Mol Sci. 2013 Jun 13;14(6):12458-83.

82)    De Berardis D, Serroni N, Marini S, Rapini G, Valchera A, Fornaro M, Mazza M, Iasevoli F, Martinotti G, Di Giannantonio M. Successful ziprasidone monotherapyin a case of delusional parasitosis: a one-year followup. Case Rep Psychiatry.

83)    De Berardis D, Conti CM, Marini S, Ferri F, Iasevoli F, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Perna G, Carano A, Piersanti M, Martinotti G, Di Giannantonio M. Is there a role for agomelatine in the treatment of anxiety disorders? a review of published data. Int J Immunopathol Pharmacol. 2013Apr-Jun;26(2):299-304.

84)    De Berardis D, Serroni N, Moschetta FS, Martinotti G, Di Giannantonio M. Reversal of aripiprazole-induced tardive akathisia by addition of pregabalin. J Neuropsychiatry Clin Neurosci. 2013 Mar 1;25(2):E09-10.

85)    Martinotti G, Di Nicola M, Tedeschi D, Callea A, Di Giannantonio M, Janiri L;  Craving Study Group. Craving Typology Questionnaire (CTQ): A scale for alcohol craving in normal controls and alcoholics. Compr Psychiatry. 2013 May 2.

86)    De Berardis D, Valchera A, Fornaro M, Serroni N, Marini S, Moschetta FS,Martinotti G, Di Giannantonio M. Agomelatine reversal of escitalopram-inducedapathy: a case report. Psychiatry Clin Neurosci. 2013 Apr;67(3):190-1.

87)    Martinotti G, Sepede G, Signorelli M, Aguglia E, Di Giannantonio M. Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review. Expert Opin Pharmacother. 2013 Jun;14(8):1065-75.

88)    Guglielmo R, Martinotti G, Di Giannantonio M, Janiri L. A possible new option for migraine management: agomelatine. Clin Neuropharmacol. 2013 Mar-Apr;36(2):65-7.

89)    De Berardis D, Marini S, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Sepede G, Martinotti G, Di Giannantonio M. The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review. CNS Neurol Disord Drug Targets. 2013Mar;12(2):252-64.

90)    Fornaro M, Ventriglio A, De Pasquale C, Pistorio ML, De Berardis D, Cattaneo CI, Favaretto E, Martinotti G, Tomasetti C, Elassy M, D'Angelo E, Mungo S, DelDebbio A, Romano A, Ciampa G, Colicchio S. Sensation seeking in major depressive patients: relationship to sub-threshold bipolarity and cyclothymic temperament. J Affect Disord. 2013 Jun;148(2-3):375-83.

91)    De Berardis D, Marini S, Carano A, Lang AP, Cavuto M, Piersanti M, Fornaro M, Perna G, Valchera A, Mazza M, Iasevoli F, Martinotti G, Di Giannantonio M. Efficacy and Safety of Long Acting Injectable Atypical Antipsychotics: A Review. Curr Clin Pharmacol. 2013 Jan 4.

92)    Sepede G, Martinotti G, Gambi F, Salerno RM, Di Giannantonio M. Lamotrigineaugmentation in premenstrual dysphoric disorder: a case report. ClinNeuropharmacol. 2013 Jan-Feb;36(1):31-3.

93)    De Berardis D, Marini S, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Sepede G, Martinotti G, Di Giannantonio M. The role of intranasal oxytocin in the treatment of patients with schizophrenia: a systematic review. CNS Neurol Disord Drug Targets. 2013  Mar.

94)    Guglielmo R, Martinotti G, Di Giannantonio M, Janiri L.  A  possible new option  for migraine management: agomelatine. Clin Neuropharmacol. 2013  Mar-Apr.

95)    De Berardis D, Valchera A, Fornaro M, Serroni N, Marini S, Moschetta FS, Martinotti G, Di Giannantonio M. Agomelatine reversal of escitalopram-induced apathy: a case report. Psychiatry Clin Neurosci. 2013 Apr.

96)    De Berardis D, Conti CM, Marini S, Ferri F, Iasevoli F, Valchera A, Fornaro M, Cavuto M, Srinivasan V, Perna G, Carano A, Piersanti M, Martinotti G, Di Giannantonio M. Is there a role for agomelatine in the treatment of anxiety disorders? a review of published data. Int J Immunopathol Pharmacol. 2013 Apr-Jun.

97)    De Berardis D, Marini S, Serroni N, Rapini G, Iasevoli F, Valchera A, Signorelli M, Aguglia E, Perna G, Salone A, Di Iorio G, Martinotti G, Di Giannantonio M. S-Adenosyl-L-Methionine augmentation in patients with stage II treatment-resistant major depressive disorder: an open label, fixed dose, single-blind study. Scientific World Journal. 2013 May 12.

98)    De-Giorgio F, Grassi VM, Chillemi E, Martinotti G. Dead under the bed: a case  of Diogenes syndrome? Int J Geriatr Psychiatry. 2013 May.

99)    Fornaro M, Ventriglio A, De Pasquale C, Pistorio ML, De Berardis D, Cattaneo CI, Favaretto E, Martinotti G, Tomasetti C, Elassy M, D'Angelo E, Mungo S, Del Debbio A, Romano A, Ciampa G, Colicchio S. Sensation seeking in major depressive  patients: relationship to sub-threshold bipolarity and cyclothymic temperament. J Affect Disord. 2013 Jun.

100)    Di Iorio G, Matarazzo I, Di Tizio L, Martinotti G. Treatment-resistant insomnia treated with pregabalin. Eur Rev Med Pharmacol Sci. 2013 Jun.

101)    Martinotti G, Sepede G, Signorelli M, Aguglia E, Di Giannantonio M. Efficacy and safety of fluoxetine monotherapy in bipolar depression: a systematic review.  Expert Opin Pharmacother. 2013 Jun.

102)    De Berardis D, Marini S, Fornaro M, Srinivasan V, Iasevoli F, Tomasetti C, Valchera A, Perna G, Quera-Salva MA, Martinotti G, di Giannantonio M. The melatonergic system in mood and anxiety disorders and the role of agomelatine: implications for clinical practice. Int J Mol Sci. 2013 Jun 13.

103)    De Berardis D, Campanella D, Serroni N, Moschetta FS, Di Emidio F, Conti C, Carano A, Acciavatti T, Di Iorio G, Martinotti G, Siracusano A, Di Giannantonio M. Alexithymia, suicide risk and serum lipid levels among adult outpatients with panic disorder. Compr Psychiatry. 2013 Jul;54(5):517-22.

104)    Ferri F, Costantini M, Salone A, Di Iorio G, Martinotti G, Chiarelli A, Merla  A, Di Giannantonio M, Gallese V. Upcoming tactile events  and body ownership in schizophrenia. Schizophr Res. 2013 Jul 5.

105)    De Berardis D, Marini S, Carano A, Lang AP, Cavuto M, Piersanti M, Fornaro M,  Perna G, Valchera A, Mazza M, Iasevoli F, Martinotti G, Di Giannantonio M. Efficacy and safety of long acting injectable atypical antipsychotics: a review. Curr Clin Pharmacol. 2013 Aug.

106)    Di Nicola M, Sala L, Romo L, Catalano V, Even C, Dubertret C, Martinotti G, Camardese G, Mazza M, Tedeschi D, Callea A, De Risio L, Guelfi JD, Rouillon F, Janiri L, Gorwood P. Adult attention-deficit/hyperactivity disorder in major depressed and bipolar subjects: role of personality traits and clinical implications. Eur Arch Psychiatry Clin Neurosci. 2013 Sep 28.

107)    Picardi A, Caroppo E, Fabi E, Proietti S, Di Gennaro G, Meldolesi GN, Martinotti G. Attachment and parenting in adult patients with anxiety disorders. Clin Pract Epidemiol Ment Health. 2013 Oct 4;9:157-63

108)    Vellante F, Cornelio M, Acciavatti T, Cinosi E, Marini S, Dezi S, De Risio L, Di Iorio G, Martinotti G, Di Giannantonio M. Treatment of resistant insomnia and major depression. Clin Ter. 2013;164(5):429-35

109)    De Berardis D, Fornaro M, Serroni N, Olivieri L, Marini S, Moschetta FS,Srinivasan V, Assetta M, Valchera A, Salone A, Martinotti G, Onofrj M, DiGiannantonio M. Agomelatine treatment of major depressive disorder in Parkinson's disease: a case series. J Neuropsychiatry Clin Neurosci. 2013 Oct 1;25(4):343-5

110)    Iasevoli F, Valchera A, Di Giovambattista E, Marconi M, Rapagnani MP, DeBerardis D, Martinotti G, Fornaro M, Mazza M, Tomasetti C, Buonaguro EF, Di Giannantonio M, Perugi G, de Bartolomeis A. Affective temperaments are associated with specific clusters of symptoms and psychopathology: a cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse. J Affect Disord. 2013 Nov;151(2):540-50

111)    Angelucci F, Ricci V, Gelfo F, Martinotti G, Brunetti M, Sepede G, Signorelli M, Aguglia E, Pettorruso M, Vellante F, Di Giannantonio M, Caltagirone C. BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure. Brain Cogn. 2013 Dec 18;84(1):118-122

112)    De Berardis D, Fornaro M, Serroni N, Marini S, Piersanti M, Cavuto M, Valchera A, Mazza M, Girinelli G, Iasevoli F, Perna G, Martinotti G, Di Giannantonio M. Treatment of antipsychotic-induced hyperprolactinemia: an update on the role of the dopaminergic receptors d2 partial agonist aripiprazole. Recent Pat Endocr Metab Immune Drug Discov. 2014 Jan;8(1):30-7.

113)    Pettorruso M, Martinotti G, Fasano A, Loria G, Di Nicola M, De Risio L, Ricciardi L, Conte G, Janiri L. Bentivoglio AR. Anhedonia in Parkinson's disease patients with and without pathological gambling: A case-control study. Psychiatry Res. 2014 Feb 28;215(2):448-52.

114)    Sepede G, Di lorio G, Lupi M, Sarchione F, Acciavatti T, Fiori F, Santacroce R, Martinotti G, Gambi F, Di Giannantonio M. Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence. Clin Neuropharmacol. 2014 Jan-Feb;37(1):17-21.

115)    De Berardis D, Brucchi M, Serroni N, Valchera A, Fornaro M, Mazza M, Martinotti G, Di Giannantonio M. Successful use of agomelatine in the treatment of major depression in a woman taking tamoxifen: a case report. Clin Neuropharmacol. 2014 Jan-Feb;37(1):31-3.

116)    De Berardis D, Serroni N, Marini S, Rapini G, Carano A, Valchera A, Iasevoli F, Mazza M, Signorelli M, Aguglia E, Perna G, Martinotti G, Varasano PA,Pressanti GL, Di Giannantonio M. Alexithymia, suicidal ideation, and serum lipid levels among drug-naïve outpatients with obsessive-compulsive disorder. Rev Bras Psiquiatr. 2014 Jan 17;0:0. [Epub ahead of print]

117)    Iasevoli F, Buonaguro EF, Marconi M, Di Giovambattista E, Rapagnani MP, De Berardis D, Martinotti G, Mazza M, Balletta R, Serroni N, Di Giannantonio M, de Bartolomeis A, Valchera A. Efficacy and clinical determinants of antipsychotic polypharmacy in psychotic patients experiencing an acute relapse and admitted to hospital stay: results from a cross-sectional and a subsequent longitudinal pilot study. ISRN Pharmacol. 2014 Jan 27;2014:762127.

118)    Corazza O, Bersani FS, Brunoro R, Valeriani G, Martinotti G, Schifano F. The diffusion of Performance and Image-Enhancing Drugs (PIEDs) on the Internet: The Abuse of the Cognitive Enhancer Piracetam. Subst Use Misuse. 2014 Dec 6;49(14):1849-56. doi: 10.3109/10826084.2014.912232.

119)    De Berardis D, Serroni N, Marini S, Fornaro M, Valchera A, Martinotti G, DI Giannantonio M, Kahn DA. Emerging mania following escitalopram withdrawal in a patient with unipolar depression managed with its reintroduction. J Psychiatr Pract. 2014 May;20(3):228-31.

120)    Lupi M, Martinotti G, Acciavatti T, Pettorruso M, Brunetti M, Santacroce R, Cinosi E, Di Iorio G, Di Nicola M, Di Giannantonio M. Pharmacological treatments in gambling disorder: a qualitative review. Biomed Res Int. 2014;2014:537306.

121)    Cera N, Bifolchetti S, Martinotti G, Gambi F, Sepede G, Onofrj M, Di  Giannantonio M, Thomas A. Amantadine and cognitive flexibility: decision making in Parkinson's patients with severe pathological gambling and other impulse control disorders. Neuropsychiatr Dis Treat. 2014 Jun 17;10:1093-101.

122)    Di Iorio G, Lupi M, Sarchione F, Matarazzo I, Santacroce R, Petruccelli F, Martinotti G, Di Giannantonio M. The endocannabinoid system: a putative role in neurodegenerative diseases. Int J High Risk Behav Addict. 2013 Dec;2(3):100-6.

123)    De Berardis D, Mazza M, Marini S, Del Nibletto L, Serroni N, Pino MC, Valchera A, Ortolani C, Ciarrocchi F, Martinotti G, Di Giannantonio M. Psychopathology, emotional aspects and psychological counselling in infertility: a review. Clin Ter. 2014;165(3):163-9.

124)    Di Nicola M, De Risio L, Pettorruso M, Caselli G, De Crescenzo F, Swierkosz-Lenart K, Martinotti G, Camardese G, Di Giannantonio M, Janiri L. Bipolar disorder and gambling disorder comorbidity: current evidence and implications for pharmacological treatment. J Affect Disord. 2014 Oct;167:285-98.

125)    De Berardis D, Campanella D, Serroni N, Rapini G, Olivieri L, Fornaro M, Valchera A, Iasevoli F, Napoletano C, Martinotti G, Giannantonio MD. Clozapine-related pericarditis during titration phase in a patient with resistant schizophrenia and concomitant valproate treatment: a case report. J Clin Psychopharmacol. 2014 Oct;34(5):649-51.

126)    Alessandri G, Fagnani C, Di Gennaro G, Meldolesi GN, Pasquini P, Caroppo E, Martinotti G, Toni A, Fabi E, Picardi A. Measurement invariance of the experiences in close relationships questionnaire across different populations. Span J Psychol. 2014 Jan;17:E22.

127)    Pettorruso M, De Risio L, Martinotti G, Di Nicola M, Ruggeri F, Conte G, Di Giannantonio M, Janiri L. Targeting the glutamatergic system to treat pathological gambling: current evidence and future perspectives. Biomed Res Int.  2014;2014:109786.

128)    Corazza O, Martinotti G, Santacroce R, Chillemi E, Di Giannantonio M, Schifano F, Cellek S. Sexual enhancement products for sale online: raising awareness of the psychoactive effects of yohimbine, maca, horny goat weed, and Ginkgo biloba. Biomed Res Int. 2014;2014:841798.

129)    Petruccelli F, Diotaiuti P, Verrastro V, Petruccelli I, Federico R, Martinotti G, Fossati A, Di Giannantonio M, Janiri L. Affective dependence and aggression: an exploratory study. Biomed Res Int. 2014;2014:805469.

130)    Petruccelli F, Diotaiuti P, Verrastro V, Petruccelli I, Carenti ML, De Berardis D, Iasevoli F, Valchera A, Fornaro M, Martinotti G, Di Giannantonio M, Janiri L. Obsessive-compulsive aspects and pathological gambling in an Italian sample. Biomed Res Int. 2014;2014:167438.

131)    Bersani FS, Corazza O, Albano G, Valeriani G, Santacroce R, Bolzan Mariotti Posocco F, Cinosi E, Simonato P, Martinotti G, Bersani G, Schifano F. 25C-NBOMe: preliminary data on pharmacology, psychoactive effects, and toxicity of a new potent and dangerous hallucinogenic drug. Biomed Res Int. 2014;2014:734749.

132)    Martinotti G, Lupi M, Acciavatti T, Cinosi E, Santacroce R, Signorelli MS, Bandini L, Lisi G, Quattrone D, Ciambrone P, Aguglia A, Pinna F, Calò S, Janiri L, di Giannantonio M. Novel psychoactive substances in young adults with and without psychiatric comorbidities. Biomed Res Int. 2014;2014:815424.

133)    Cinosi E, Corazza O, Santacroce R, Lupi M, Acciavatti T, Martinotti G, di Giannantonio M. New drugs on the Internet: the case of Camfetamine. Biomed Res Int. 2014;2014:419026.

134)    Corazza O, Valeriani G, Bersani FS, Corkery J, Martinotti G, Bersani G, Schifano F. "Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web. J Psychoactive Drugs. 2014 Sep-Oct;46(4):287-94.

135)    Vento AE, Martinotti G, Cinosi E, Lupi M, Acciavatti T, Carrus D, Santacroce R, Chillemi E, Bonifaci L, di Giannantonio M, Corazza O, Schifano F. Substance use in the club scene of Rome: a pilot study. Biomed Res Int. 2014;2014:617546.

136)    Martinotti G, Di Nicola M, De Vita O, Hatzigiakoumis DS, Guglielmo R, Santucci B, Aliotta F, Romanelli R, Verrastro V, Petruccelli F, Di Giannantonio M, Janiri  L. Low-dose topiramate in alcohol dependence: a single-blind, placebo-controlled  study. J Clin Psychopharmacol. 2014 Dec;34(6):709-15.

137)    Fornaro M, De Berardis D, De Pasquale C, Indelicato L, Pollice R, Valchera A,  Perna G, Iasevoli F, Tomasetti C, Martinotti G, Koshy AS, Fasmer OB, Oedegaard KJ. Prevalence and clinical features associated to bipolar disorder-migraine comorbidity: a systematic review. Compr Psychiatry. 2015 Jan;56C:1-16.

138)    Galderisi S, Rossi A, Rocca P, Bertolino A, Mucci A, Bucci P, Rucci P, Gibertoni D, Aguglia E, Amore M, Bellomo A, Biondi M, Brugnoli R, Dell'Osso L, De Ronchi D, Di Emidio G, Di Giannantonio M, Fagiolini A, Marchesi C, Monteleone P,  Oldani L, Pinna F, Roncone R, Sacchetti E, Santonastaso P, Siracusano A, Vita A,  Zeppegno P, Maj M; Italian Network For Research on Psychoses. The influence of illness-related variables, personal resources and context-related factors on real-life functioning of people with schizophrenia. World Psychiatry. 2014 Oct;13(3):275-87.

139)    Pettorruso M, De Risio L, Di Nicola M, Martinotti G, Conte G, Janiri L. Allostasis as a conceptual framework linking bipolar disorder and addiction. Front Psychiatry. 2014 Dec 3;5:173.

140)    De Berardis D, Fornaro M, Serroni N, Campanella D, Rapini G, Olivieri L, Srinivasan V, Iasevoli F, Tomasetti C, De Bartolomeis A, Valchera A, Perna G, Mazza M, Di Nicola M, Martinotti G, Di Giannantonio M. Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression. Int J Mol Sci. 2015 Jan 5;16(1):1111-30.

141)    De Berardis D, Serroni N, Campanella D, Rapini G, Olivieri L, Feliziani B, Carano A, Valchera A, Iasevoli F, Tomasetti C, Mazza M, Fornaro M, Perna G, Di Nicola M, Martinotti G, Di Giannantonio M. Alexithymia, responsibility attitudes  and suicide ideation among outpatients with obsessive-compulsive disorder: an exploratory study. Compr Psychiatry. 2015 Apr;58:82-7.

142)    Martinotti G, Corazza O, Achab S, Demetrovics Z. Novel psychoactive substances
and behavioral addictions. Biomed Res Int. 2014;2014:534523.

143)    De Berardis D, Conti C, Iasevoli F, Valchera A, Fornaro M, Cavuto M, Brucchi M, Perna G, Pompili M, Modabbernia A, Lucidi G, Mazza M, Martinotti G, Di Giannantonio M. Alexithymia and its relationships with acute phase proteins and cytokine release: an updated review. J Biol Regul Homeost Agents. 2014 Oct-Dec;28(4):795-9.

144)    Di Nicola M, Tedeschi D, De Risio L, Pettorruso M, Martinotti G, Ruggeri F, Swierkosz-Lenart K, Guglielmo R, Callea A, Ruggeri G, Pozzi G, Di Giannantonio M, Janiri L. Co-occurrence of alcohol use disorder and behavioral addictions: relevance of impulsivity and craving. Drug Alcohol Depend. 2015 Mar 1;148:118-25.

145)    Signorelli MS, Cinconze M, Nasca MR, Marino M, Martinotti G, Di Giannantonio M, Aguglia E. Can topiramate induce pruritus? A case report and review of literature. CNS Neurol Disord Drug Targets. 2015;14(3):309-12.

146)    Fornaro M, De Berardis D, Mazza M, Pino M, Favaretto E, Bedani F, Wieser C, Indelicato L, Paternò VF, Lo Monaco F, Dugo F, Ventriglio A, Mungo S, Selle V, Valchera A, Elassy M, Martinotti G, De Bartolomeis A, Iasevoli F, Tomasetti C, Avvisati L, Tartaglione S, Perna G, Cattaneo CI, Consoli G, Romano A, Del Debbio  A, Martino M, D׳Angelo E, De Pasquale C, Koshy AS, Angst J. Factor structure and  reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2). J Affect Disord. 2015 Jun 1;178:112-120.

147)    De Berardis D, Serroni N, Campanella D, Marini S, Rapini G, Valchera A, Iasevoli F, Mazza M, Fornaro M, Perna G, Di Iorio G, Martinotti G, Di Giannantonio M. Alexithymia, Suicide Ideation, C-Reactive Protein and Serum Lipid Levels among Outpatients with Generalized Anxiety Disorder. Arch Suicide Res. 2015 Apr 9.

148)    Guglielmo R, Martinotti G, Quatrale M, Ioime L, Kadilli I, Di Nicola M, Janiri L. Topiramate in Alcohol Use Disorders: Review and Update. CNS Drugs. 2015 Apr 22..

149)    De Berardis D, Marini S, Serroni N, Iasevoli F, Tomasetti C, Bartolomeis A, Mazza M, Tempesta D, Valchera A, Fornaro M, Pompili M, Sepede G, Vellante F, Orsolini L, Martinotti G, Giannantonio MD. Targeting The Noradrenergic System In Posttraumatic Stress Disorder: A Systematic Review And Meta-Analysis Of Prazosin  Trials. Curr Drug Targets. 2015 May 6

150)    De Berardis D, Brucchi M, Serroni N, Rapini G, Campanella D, Vellante F, Valchera A, Fornaro M, Iasevoli F, Mazza M, Lucidi G, Martinotti G, di Giannantonio M. Cotard's Syndrome after breast surgery successfully treated with aripiprazole augmentation of escitalopram: a case report. Riv Psichiatr. 2015 Mar-Apr;50(2):95-8. 

151)    Pettorruso M, Di Nicola M, De Risio L, Fasano A, Martinotti G, Conte G, Bentivoglio AR, Janiri L. Punding behavior in bipolar disorder type 1: case report. J Neuropsychiatry Clin Neurosci. 2014 Fall;26(4):E8-9. 

152)    Bersani FS, Corazza O, Albano G, Bruschi S, Minichino A, Vicinanza R, Bersani G, Martinotti G, Schifano F. The "Eyeballing" technique: an emerging and alerting trend of alcohol misuse. Eur Rev Med Pharmacol Sci. 2015 Jun;19(12):2311-7.

153)    Santacroce R, Corazza O, Martinotti G, Bersani FS, Valeriani G, Di Giannantonio M. Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products. Hum Psychopharmacol. 2015 Jul;30(4):265-71. 

154)    Martinotti G, Lupi M, Carlucci L, Cinosi E, Santacroce R, Acciavatti T, Chillemi E, Bonifaci L, Janiri L, Di Giannantonio M. Novel psychoactive substances: use and knowledge among adolescents and young adults in urban and rural areas. H Psychopharmacol. 2015 Jul;30(4):295-301.

155)    Dell'Osso B, Albert U, Atti AR, Carmassi C, Carrà G, Cosci F, Del Vecchio V,  Di Nicola M, Ferrari S, Goracci A, Iasevoli F, Luciano M, Martinotti G, Nanni MG, Nivoli A, Pinna F, Poloni N, Pompili M, Sampogna G, Tarricone I, Tosato S, Volpe U, Fiorillo A. Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice. Neuropsychiatr Dis Treat. 2015 Jul 30;11:1885-909. 

156)    Martinotti G, Sepede G, Brunetti M, Ricci V, Gambi F, Chillemi E, Vellante F, Signorelli M, Pettorruso M, De Risio L, Aguglia E, Angelucci F, Caltagirone C, Di Giannantonio M. BDNF concentration and impulsiveness level in post-traumatic stress disorder. Psychiatry Res. 2015 Oct 30;229(3):814-8. 

157)    De Berardis D, Orsolini L, Serroni N, Girinelli G, Iasevoli F, Tomasetti C, de Bartolomeis A, Mazza M, Valchera A, Fornaro M, Perna G, Piersanti M, Di Nicola M, Cavuto M, Martinotti G, Di Giannantonio M. A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder. CNS Neurol Disord Drug Targets. 2016;15(1):35-44. 

158)    De Risio L, Pettorruso M, Di Nicola M, Martinotti G, Janiri L, Fasano A. Management of aripiprazole-induced tardive Pisa syndrome: a case report and literature review. Int Clin Psychopharmacol. 2016 Jan;31(1):57-60. 

159)    Marini S, Di Tizio L, Dezi S, Armuzzi S, Pelaccia S, Valchera A, Sepede G, Girinelli G, De Berardis D, Martinotti G, Gambi F, Di Giannantonio M. The bridge between two worlds: psychoanalysis and fMRI. Rev Neurosci. 2016 Feb 1;27(2):219-29. 

160)    Nosè M, Bighelli I, Castellazzi M, Martinotti G, Carrà G, Lucii C, Ostuzzi G, Sozzi F, Barbui C; STAR NETWORK GROUP. Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study. Epidemiol Psychiatr Sci. 2015 Oct 15:1-9. 

161)    Cinosi E, Martinotti G, Simonato P, Singh D, Demetrovics Z, Roman-Urrestarazu A, Bersani FS, Vicknasingam B, Piazzon G, Li JH, Yu WJ, Kapitány-Fövény M, Farkas J, Di Giannantonio M, Corazza O. Following "the Roots" of Kratom (Mitragyna speciosa): The Evolution of an Enhancer from a Traditional Use to Increase Work and Productivity in Southeast Asia to a Recreational Psychoactive Drug in Western Countries. Biomed Res Int. 2015; 2015: 968786. 

162)    Marini S, Vellante F, Matarazzo I, De Berardis D, Serroni N, Gianfelice D, Olivieri L, Di Renzo F, Di Marco A, Fornaro M, Orsolini L, Valchera A, Iasevoli F, Mazza M, Perna G, Martinotti G, Di Giannantonio M. Inflammatory markers and suicidal attempts in depressed patients: A review. Int J Immunopathol Pharmacol.  2016 Jan 4. pii: 0394632015623793. 

163)    Martinotti G, Pettorruso M, De Berardis D, Varasano PA, Lucidi Pressanti G, De Remigis V, Valchera A, Ricci V, Di Nicola M, Janiri L, Biggio G, Di Giannantonio M. Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms. Int J Neuropsychopharmacol. 2016 Jan16. 

164)    Barbui C, Bighelli I, Carrà G, Castellazzi M, Lucii C, Martinotti G, Nosè M, Ostuzzi G; STAR NETWORK INVESTIGATORS. Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval. PLoS One. 2016 Feb 3;11(2):e0148212. 

165)    Salone A, Di Giacinto A, Lai C, De Berardis D, Iasevoli F, Fornaro M, De Risio L, Santacroce R, Martinotti G, Giannantonio MD. The Interface between Neuroscience and Neuro-Psychoanalysis: Focus on Brain Connectivity. Front Hum Neurosci. 2016 Feb 3;10:20. 

166)    Pettorruso M, Fasano A, De Risio L, Ricciardi L, Di Nicola M, Martinotti G, Janiri L, Bentivoglio AR. Punding in non-demented Parkinson's disease patients: Relationship with psychiatric and addiction spectrum comorbidity. J Neurol Sci. 2016 Mar 15;362:344-7. 

167)    Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Vellante F, Fornaro M, Fiengo A, Mazza M, Vecchiotti R, Perna G, de Bartolomeis A, Martinotti G, Di Giannantonio M, De Berardis D. New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine. Expert Rev Neurother. 2016 May;16(5):483-95. 

168)    Martinotti G, Orsolini L, Fornaro M, Vecchiotti R, De Berardis D, Iasevoli F, Torrens M, Di Giannantonio M. Aripiprazole for relapse prevention and craving in alcohol use disorder: current evidence and future perspectives. Expert OpinInvestig Drugs. 2016 Apr 21:1-10

169)    Luciano M, Sampogna G, Del Vecchio V, De Rosa C, Albert U, Carrà G, Dell'Osso  B, Lorenzo GD, Ferrari S, Martinotti G, Nanni MG, Pinna F, Pompili M, Volpe U, Catapano F, Fiorillo A. [Critical evaluation of current diagnostic classification systems in psychiatry: the case of DSM-5]. Riv Psichiatr. 2016 May-Jun;51(3):116-21

170)    De Berardis D, Orsolini L, Iasevoli F, Prinzivalli E, de Bartolomeis A, Serroni N, Mazza M, Valchera A, Fornaro M, Vecchiotti R, Carano A, Sepede G, Vellante F, Matarazzo I, Pompili M, Perna G, Conti C, Segura-García C, Martinotti G, Di Giannantonio M. The Novel Antipsychotic Cariprazine (RGH-188): State-of-the-Art in the Treatment of Psychiatric Disorders. Curr Pharm Des. 2016;22(33): 5144-5162

171)    Marini S, De Berardis D, Vellante F, Santacroce R, Orsolini L, Valchera A, Girinelli G, Carano A, Fornaro M, Gambi F, Martinotti G, Di Giannantonio M. Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials. Mediators Inflamm. 2016;2016: 3476240

172)    Martinotti G, Lupi M, Carlucci L, Santacroce R, Cinosi E, Acciavatti T, Sarchione F, Verrastro V, Diotaiuti P, Petruccelli I, Ferrari S, Nanni MG, Pinna  F, Volpe U, Saggino A, Janiri L, Leggio L, Di Giannantonio M. Alcohol drinking patterns in young people: A survey-based study. J Health Psychol. 2016 Sep 13

173)    De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, De Lauretis I, Girinelli G, Mazza M, Valchera A, Carano A, Vellante F, Matarazzo I, Perna G, Martinotti G, Di Giannantonio M. Effect of agomelatine treatment on C-reactive protein levels in patients with major depressive disorder: an exploratory study in "real-world," everyday clinical practice CNS Spectr. 2016 Oct 5:1-6

174)    Al-Imam A, Santacroce R, Roman-Urrestarazu A, Chilcott R, Bersani G, Martinotti G, Corazza O. Captagon: use and trade in the Middle East. Hum Psychopharmacol. 2016 Oct 21

175)    Orsolini L, Tomasetti C, Valchera A, Iasevoli F, Buonaguro EF, Fornaro M, Fiengo AL, Martinotti G, Vellante F, Matarazzo I, Vecchiotti R, Perna G, Di Nicola M, Carano A, de Bartolomeis A, Di Giannantonio M, De Berardis D. Current and future perspectives on the Major Depressive Disorder: Focus on the new multimodal antidepressant Vortioxetine. CNS Neurol Disord Drug Targets. 2016

176)    Nosè M, Bighelli I, Castellazzi M, Martinotti G, Carrà G, Lucii C, Ostuzzi G, Sozzi F, Barbui C; STAR NETWORK GROUP.. Prevalence and correlates of QTc prolongation in Italian psychiatric care: cross-sectional multicentre study. Epidemiol Psychiatr Sci. 2016 Dec;25(6):532-540

177)    Gargoloff PD, Corral R, Herbst L, Marquez M, Martinotti G, Gargoloff PR. Effectiveness of agomelatine on anhedonia in depressed patients: an outpatient, open-label, real-world study. Hum Psychopharmacol. 2016 Nov;31(6):412-418. 

178)    Acciavatti T, Martinotti G, Corbo M, Cinosi E, Lupi M, Ricci F, Di Scala R, D'Ugo E, De Francesco V, De Caterina R, di Giannantonio M. Psychotropic drugs and ventricular repolarisation: The effects on QT interval, T-peak to T-end interval and QT dispersion. J Psychopharmacol. 2017 Apr;31(4):453-460. 

179)    Tomasetti C, Iasevoli F, Buonaguro EF, De Berardis D, Fornaro M, Fiengo AL, Martinotti G, Orsolini L, Valchera A, Di Giannantonio M, de Bartolomeis A. Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions. Int J Mol Sci. 2017 Jan 12;18(1). 

180)    De Berardis D, Fornaro M, Orsolini L, Iasevoli F, Tomasetti C, de Bartolomeis A, Serroni N, Valchera A, Carano A, Vellante F, Marini S, Piersanti M, Perna G, Martinotti G, Di Giannantonio M. The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review. Int J Mol Sci. 2017 Feb 8;18(2). 

181)    Lupi M, Martinotti G, Santacroce R, Cinosi E, Carlucci M, Marini S, Acciavatti T, di Giannantonio M. Transcranial Direct Current Stimulation in Substance Use Disorders: A Systematic Review of Scientific Literature. J ECT. 2017 Mar 8. 

182)    Brunetti M, Marzetti L, Sepede G, Zappasodi F, Pizzella V, Sarchione F, Vellante F, Martinotti G, Di Giannantonio M. Resilience and cross-network connectivity: A neural model for post-trauma survival. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 3;77:110-119. 

183)    Martinotti G, Santacroce R, Papanti D, Elgharably Y, Prilutskaya M, Corazza O. Synthetic Cannabinoids: psychopharmacology, clinical aspects, and psy-chotic onset. CNS Neurol Disord Drug Targets. 2017 Apr 13. 

184)    Moccia L, Pettorruso M, De Crescenzo F, De Risio L, di Nuzzo L, Martinotti G, Bifone A, Janiri L, Di Nicola M. Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies. Neurosci Biobehav Rev. 2017 Jul;78:104-116. 

185)    Janiri D, Di Nicola M, Martinotti G, Janiri L. Who's the Leader, Mania or Depression? Predominant Polarity and Alcohol/Polysubstance Use in Bipolar Disorders. Curr Neuropharmacol. 2017 Apr;15(3):409-416. 

186)    Acciavatti T, Lupi M, Santacroce R, Aguglia A, Attademo L, Bandini L, Ciambrone P, Lisi G, Migliarese G, Pinna F, Quattrone D, Ribolsi M, Signorelli MS, Calò S, Schifano F, di Giannantonio M, Martinotti G. Novel psychoactive substance consumption is more represented in bipolar disorder than in psychotic disorders: A multicenter-observational study. Hum Psychopharmacol. 2017 May;32(3). 

187)    Sala L, Martinotti G, Carenti ML, Romo L, Oumaya M, Pham-Scottez A, Rouillon F, Gorwood P, Janiri L. Attention-deficit/hyperactivity disorder symptoms and psychological comorbidity in eating disorder patients. Eat Weight Disord. 2017 May 22. 

188)    Di Nicola M, De Filippis S, Martinotti G, De Risio L, Pettorruso M, De Persis S, Maremmani AGI, Maremmani I, di Giannantonio M, Janiri L. Nalmefene in Alcohol Use Disorder Subjects with Psychiatric Comorbidity: A Naturalistic Study. Adv Ther. 2017 Jul;34(7):1636-1649. 

189)    Santacroce R, Martinotti G, di Giannantonio M. The light at the end of the tunnel is a train: Risky behaviours in the era of social networks. Int J Soc Psychiatry. 2017 Aug;63(5):468-469. 

190)    Martinotti G, Cinosi E, Santacroce R, Papanti D, Pasquini A, Mancini V, Corbo M, Fiori F, Sarchione F, Marchetti D, Verrocchio MC, Di Giannantonio M, Torrens M, Schifano F, Morlan Coarasa MJ, Merino Del Villar C. Substance-related psychopathology and aggressiveness in a nightlife holiday resort: Results from a  pilot study in a psychiatric inpatient unit in Ibiza. Hum Psychopharmacol. 2017 May;32(3). 

191)    Simonato P, Bersani FS, Santacroce R, Cinosi E, Schifano F, Bersani G, Martinotti G, Corazza O. Can mobile phone technology support a rapid sharing of information on novel psychoactive substances among health and other professionals internationally? Hum Psychopharmacol. 2017 May;32(3). 

192)    Shafi A, Gallagher P, Stewart N, Martinotti G, Corazza O. The risk of violence associated with novel psychoactive substance misuse in patients presenting to acute mental health services. Hum Psychopharmacol. 2017 May;32(3). 

193)    Santacroce R, Ruiz Bennasar C, Sancho Jaraiz JR, Fiori F, Sarchione F, Angelini F, Catalano G, Carenti ML, Corkery JM, Schifano F, Di Giannantonio M, Martinotti G. A matter of life and death: substance-caused and substance-related fatalities in Ibiza in 2015. Hum Psychopharmacol. 2017 May;32(3). 

194)    Mooney R, Simonato P, Ruparelia R, Roman-Urrestarazu A, Martinotti G, Corazza O. The use of supplements and performance and image enhancing drugs in fitness settings: A exploratory cross-sectional investigation in the United Kingdom. Hum  Psychopharmacol. 2017 May;32(3). 

195)    Vellante F, Sarchione F, Ebisch SJH, Salone A, Orsolini L, Marini S, Valchera A, Fornaro M, Carano A, Iasevoli F, Martinotti G, Di Giannantonio M, De Berardis D. Creativity and psychiatric illness: A functional perspective beyond chaos. Prog Neuropsychopharmacol Biol Psychiatry. 2017 Jul 5. pii: S0278-5846(17)30081-7

196)    Ebisch SJH, Gallese V, Salone A, Martinotti G, di Iorio G, Mantini D, Perrucci MG, Romani GL, Di Giannantonio M, Northoff G. Disrupted relationship between "resting state" connectivity and task-evoked activity during social perception in schizophrenia. Schizophr Res. 2017 Jul 20. pii: S0920-9964(17)30421-8

197)    Martinotti G, Montemitro C, Baroni G, Andreoli S, Alimonti F, Di Nicola M, Tonioni F, Leggio L, di Giannantonio M, Janiri L. Relationship between craving and plasma leptin concentrations in patients with cocaine addiction. Psychoneuroendocrinology. 2017 Nov;85:35-41. 

198)    Lupi M, Martinotti G, Di Giannantonio M. Drunkorexia: an emerging trend in young adults. Eat Weight Disord. 2017 Dec;22(4):619-622. 

199)    De Berardis D, Fornaro M, Orsolini L, Valchera A, Carano A, Vellante F, Perna, G, Serafini G, Gonda X, Pompili M, Martinotti G, Di Giannantonio M. Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review. Front Psychiatry. 2017  Aug 14;8:148. 

200)    Meid AD, Bighelli I, Mächler S, Mikus G, Carrà G, Castellazzi M, Lucii C, Martinotti G, Nosè M, Ostuzzi G, Barbui C, Haefeli WE. Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature. Ther Adv Psychopharmacol. 2017 Dec;7(12):251-264. 

201)    Di Nicola M, Ferri VR, Moccia L, Panaccione I, Strangio AM, Tedeschi D, Grandinetti P, Callea A, De-Giorgio F, Martinotti G, Janiri L. Gender Differences and Psychopathological Features Associated With Addictive Behaviors in Adolescents. Front Psychiatry. 2017 Dec 1;8:256. 

202)    Di Cosmo G, Costantini M, Salone A, Martinotti G, Di Iorio G, Di Giannantonio M, Ferri F. Peripersonal space boundary in schizotypy and schizophrenia. Schizophr Res. 2017 Dec 18. pii: S0920-9964(17)30755-7. 

203)    Lupi M, Sepede G, Cinosi E, Martinotti G, di Giannantonio M. The Efficacy of Transcranical Direct Current Stimulation in Pregabalin Abuse: A Case Report. J ECT. 2018 Jan 11. 

204)    Orsolini L, Sarchione F, Vellante F, Fornaro M, Matarazzo I, Martinotti G, Valchera A, Di Nicola M, Carano A, Di Giannantonio M, Perna G, Olivieri L, De Berardis D. Protein-C reactive as biomarker predictor of schizophrenia phases of illness? A systematic review. Curr Neuropharmacol. 2018 Jan 19. 

205)    Catalani V, Prilutskaya M, Al-Imam A, Marrinan S, Elgharably Y, Zloh M, Martinotti G, Chilcott R, Corazza O. Octodrine: New Questions and Challenges in Sport Supplements. Brain Sci. 2018 Feb 20;8(2).

206)    De Berardis D, Martinotti G, Di Giannantonio M. Understanding the Complex Phenomenon of Suicide: From Research to Clinical Practice. Front Psychiatry. 2018 Mar 1;9:61.

207)    Martinotti G, Santacroce R, Pettorruso M, Montemitro C, Spano MC, Lorusso M, di Giannantonio M, Lerner AG. Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives. Brain Sci. 2018 Mar 16;8(3).

208)    Bonanni L, Franciotti R, Martinotti G, Vellante F, Flacco ME, Di Giannantonio M, Thomas A, Onofrj M. Post Traumatic Stress Disorder Heralding the Onset of Semantic Frontotemporal Dementia. J Alzheimers Dis. 2018;63(1):203-215.

209)    Ioime L, Guglielmo R, Affini GF, Quatrale M, Martinotti G, Callea A, Savi E, Janiri L. Neuropsychological Performance in Alcohol Dependent Patients: A One-Year Longitudinal Study. Psychiatry Investig. 2018 Apr 20. doi: 10.30773/pi.2017.09.27.1.

210)    Metastasio A, Negri A, Martinotti G, Corazza O. Transitioning Bodies. The Case of Self-Prescribing Sexual Hormones in Gender Affirmation in Individuals Attending Psychiatric Services. Brain Sci. 2018 May 14;8(5).

211)    De Berardis D, Rapini G, Olivieri L, Di Nicola D, Tomasetti C, Valchera A, Fornaro M, Di Fabio F, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Martinotti G, Di Giannantonio M. Safety of antipsychotics for the treatment of schizophrenia: a focus on the adverse effects of clozapine. Ther Adv Drug Saf. 2018 May;9(5):237-256.

212)    Pettorruso M, Spagnolo PA, Leggio L, Janiri L, Di Giannantonio M, Gallimberti L, Bonci A, Martinotti G. Repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex may improve symptoms of anhedonia in individuals with cocaine use disorder: A pilot study. Brain Stimul. 2018 Jun 5.

213)    Ostuzzi G, Mazzi MA, Terlizzi S, Bertolini F, Aguglia A, Bartoli F, Bortolaso P, Callegari C, Caroleo M, Carrà G, Corbo M, D'Agostino A, Gastaldon C, Lucii C, Magliocco F, Martinotti G, Nosé M, Ostinelli EG, Papola D, Piccinelli MP, Piccoli A, Purgato M, Tabacchi T, Turrini G, Ruggeri M, Barbui C; STAR Network. Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy.  PLoS One. 2018 Aug 2;13(8):e0201371.

214)    Pettorruso M, Martinotti G, Cocciolillo F, De Risio L, Cinquino A, Di Nicola M, Camardese G, Migliara G, Moccia L, Conte E, Janiri L, Di Giuda D. Striatal presynaptic dopaminergic dysfunction in gambling disorder: A (123) I-FP-CIT SPECT study. Addict Biol. 2018 Sep 18. 

215)    De Berardis D, Fornaro M, Valchera A, Cavuto M, Perna G, Di Nicola M, Serafini G, Carano A, Pompili M, Vellante F, Orsolini L, Fiengo A, Ventriglio A, Yong-Ku K, Martinotti G, Di Giannantonio M, Tomasetti C. Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors. Int J Mol Sci. 2018 Sep 23;19(10).

216)    Martinotti G, Chillemi E, Lupi M, Risio L, Pettorruso M, Giannantonio MD. Gambling disorder and bilateral transcranial direct current stimulation: A case report. J Behav Addict. 2018 Sep 1;7(3):834-837. 

217)    Santacroce R, Martinotti G, di Giannantonio M. Shedding light on the "Blackout": risky behaviors and accidental deaths among adolescents. Acta Psychiatr Scand. 2019 Jan;139(1):98-99. 

218)    Clerici M, de Bartolomeis A, De Filippis S, Ducci G, Maremmani I, Martinotti G, Schifano F. Patterns of Management of Patients With Dual Disorder (Psychosis)  in Italy: A Survey of Psychiatrists and Other Physicians Focusing on Clinical Practice. Front Psychiatry. 2018 Nov 13;9:575.

219)    Fineberg NA, Demetrovics Z, Stein DJ, Ioannidis K, Potenza MN, Grünblatt E, Brand M, Billieux J, Carmi L, King DL, Grant JE, Yücel M, Dell'Osso B, Rumpf HJ,  Hall N, Hollander E, Goudriaan A, Menchon J, Zohar J, Burkauskas J, Martinotti G, Van Ameringen M, Corazza O, Pallanti S; COST Action Network, Chamberlain SR. Manifesto for a European research network into Problematic Usage of the Internet. Eur Neuropsychopharmacol. 2018 Nov;28(11):1232-1246. 

220)    Moccia L, Tofani A, Mazza M, Covino M, Martinotti G, Schifano F, Janiri L, Di  Nicola M. Dorsolateral Prefrontal Cortex Impairment in Methoxetamine-Induced Psychosis: An (18)F-FDG PET/CT Case Study. J Psychoactive Drugs. 2019 Feb 9:1-6.

221)    Pettorruso M, Di Giuda D, Martinotti G, Cocciolillo F, De Risio L, Montemitro  C, Camardese G, Di Nicola M, Janiri L, di Giannantonio M; NST Study Group. Dopaminergic and clinical correlates of high-frequency repetitive transcranial magnetic stimulation in gambling addiction: a SPECT case study. Addict Behav. 2019 Feb 14;93:246-249. 

222)    Martinotti G, Lupi M, Montemitro C, Miuli A, Di Natale C, Spano MC, Mancini V, Lorusso M, Stigliano G, Tambelli A, Di Carlo F, Di Caprio L, Fraticelli S, Chillemi E, Pettorruso M, Sepede G, di Giannantonio M. Transcranial Direct Current Stimulation Reduces Craving in Substance Use Disorders: A Double-blind, Placebo-Controlled Study. J ECT. 2019 Sep;35(3):207-211.

223)    Tomasetti C, Montemitro C, Fiengo ALC, Santone C, Orsolini L, Valchera A, Carano A, Pompili M, Serafini G, Perna G, Vellante F, Martinotti G, Giannantonio MD, Kim YK, Nicola MD, Bellomo A, Ventriglio A, Fornaro M, Berardis DD. Novel Pathways in the Treatment of Major Depression: Focus on the Glutamatergic System. Curr Pharm Des. 2019;25(4):381-387

224)    De Berardis D, Olivieri L, Rapini G, Di Natale S, Serroni N, Fornaro M, Orsolini L, Valchera A, Carano A, Vellante F, Varasano PA, Lucidi Pressanti G, Serafini G, Pompili M, Martinotti G, Di Giannantonio M. Alexithymia, Suicide Ideation and Homocysteine Levels in Drug Naïve Patients with Major Depression: A Study in the "Real World" Clinical Practice. Clin Psychopharmacol Neurosci. 2019 May 31;17(2):318-322

225)    Di Giannantonio M, Montemitro C, Sepede G, Brunetti M, Baroni G, Corbo M, Anders M, Tavčar R, Martinotti G, Manzoli L. Agomelatine Effectiveness, Tolerability, and Impact on Anhedonia in Major Depression: A Pooled Analysis. J Clin Psychopharmacol. 2019 May/Jun;39(3):288-290

226)    Corazza O, Simonato P, Demetrovics Z, Mooney R, van de Ven K, Roman-Urrestarazu A, Rácmolnár L, De Luca I, Cinosi E, Santacroce R, Marini M, Wellsted D, Sullivan K, Bersani G, Martinotti G. The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study. PLoS One. 2019 Apr 3;14(4):e0213060

227)    Balestri M, Porcelli S, Souery D, Kasper S, Dikeos D, Ferentinos P, Papadimitriou GN, Rujescu D, Martinotti G, Di Nicola M, Janiri L, Caletti E, Mandolini GM, Pigoni A, Paoli RA, Lazzaretti M, Brambilla P, Sala M, Abbiati V, Bellani M, Perlini C, Rossetti MG, Piccin S, Bonivento C, Fabbro D, Damante G, Ferrari C, Rossi R, Pedrini L, Benedetti F, Montgomery S, Zohar J, Mendlewicz J, Serretti A. Temperament and character influence on depression treatment outcome. J Affect Disord. 2019 Jun 1;252:464-474

228)    Fornaro M, Anastasia A, Valchera A, Carano A, Orsolini L, Vellante F, Rapini G, Olivieri L, Di Natale S, Perna G, Martinotti G, Di Giannantonio M, De Berardis D.
The FDA "Black Box" Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits? Front Psychiatry. 2019 May 3;10:294

229)    Martinotti G, Montemitro C, Pettorruso M, Viceconte D, Alessi MC, Di Carlo F, Lucidi L, Picutti E, Santacroce R, Di Giannantonio M. Augmenting pharmacotherapy with neuromodulation techniques for the treatment of bipolar disorder: a focus on the effects of mood stabilizers on cortical excitability. Expert Opin Pharmacother. 2019 Sep;20(13):1575-1588

230)    Ekhtiari H, Tavakoli H, Addolorato G, Baeken C, Bonci A, Campanella S, Castelo-Branco L, Challet-Bouju G, Clark VP, Claus E, Dannon PN, Del Felice A, den Uyl T, Diana M, di Giannantonio M, Fedota JR, Fitzgerald P, Gallimberti L, Grall-Bronnec M, Herremans SC, Herrmann MJ, Jamil A, Khedr E, Kouimtsidis C, Kozak K, Krupitsky E, Lamm C, Lechner WV, Madeo G, Malmir N, Martinotti G, McDonald WM, Montemitro C, Nakamura-Palacios EM, Nasehi M, Noël X, Nosratabadi M, Paulus M, Pettorruso M, Pradhan B, Praharaj SK, Rafferty H, Sahlem G, Salmeron BJ, Sauvaget A, Schluter RS, Sergiou C, Shahbabaie A, Sheffer C, Spagnolo PA, Steele VR, Yuan TF, van Dongen JDM, Van Waes V, Venkatasubramanian G, Verdejo-García A, Verveer I, Welsh JW, Wesley MJ, Witkiewitz K, Yavari F, Zarrindast MR, Zawertailo L, Zhang X, Cha YH, George TP, Frohlich F, Goudriaan AE, Fecteau S, Daughters SB, Stein EA, Fregni F, Nitsche MA, Zangen A, Bikson M, Hanlon CA. Transcranial electrical and magnetic stimulation (tES and TMS) for addiction medicine: A consensus paper on the present state of the science and the road ahead. Neurosci Biobehav Rev. 2019 Sep;104:118-140

231)    Off-Label Use of Second-generation Antipsychotics in Bipolar Disorder: A Survey of Italian Psychiatrists. Salvi V, Cerveri G, Aguglia A, Calò S, Corbo M, Martinotti G, Serafini G, Signorelli MS, Aguglia E, Amore M, Biggio G, DI Sciascio G, Mencacci C. J Psychiatr Pract. 2019 Jul;25(4):318-327

232)    De Berardis D, Fornaro M, Valchera A, Rapini G, Di Natale S, De Lauretis I, Serroni N, Orsolini L, Tomasetti C, Bustini M, Carano A, Vellante F, Perna G, Core L, Alessandrini M, Fraticelli S, Martinotti G, Di Giannantonio M. Alexithymia, resilience, somatic sensations and their relationships with suicide ideation in drug naïve patients with first-episode major depression: An exploratory study in the "real world" everyday clinical practice. Early Interv Psychiatry. 2019 Aug 11

233)    De Berardis D, Vellante F, Fornaro M, Orsolini L, Valchera A, Baroni G, Kim YK, Martinotti G, Di Giannantonio M. Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report. Int Clin Psychopharmacol. 2019 Aug 20
234)    Pettorruso M, Martinotti G, Santacroce R, Montemitro C, Fanella F, di Giannantonio M; rTMS stimulation group. rTMS Reduces Psychopathological Burden and Cocaine Consumption in Treatment-Seeking Subjects With Cocaine Use Disorder: An Open Label, Feasibility Study. Front Psychiatry. 2019 Sep 5;10:621.

235)    Calabrò M, Mandelli L, Crisafulli C, Porcelli S, Albani D, Politis A, Papadimitriou GN, Di Nicola M, Janiri L, Colombo R, Martinotti G, Bellomo A, Vieta E, Bonassi S, Frustaci A, Ducci G, Landi S, Boccia S, Serretti A. Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer's disease. Mol Biol Rep. 2020 Jan;47(1):191-200

236)    Aguglia A, Serafini G, Nebbia J, Salvi V, Martinotti G, Corbo M, Signorelli MS, Mineo L, Mencacci C, Di Sciascio G, Biggio G, Aguglia E, Amore M. Off-Label Use of Second-Generation Antipsychotics in Borderline Personality Disorder: A Survey of Italian Psychiatrists. J Pers Disord. 2019 Oct 14:1-15.

237)    Spano MC, Lorusso M, Pettorruso M, Zoratto F, Di Giuda D, Martinotti G, di Giannantonio M. Anhedonia across borders: Transdiagnostic relevance of reward dysfunction for noninvasive brain stimulation endophenotypes. CNS Neurosci Ther. 2019 Nov;25(11):1229-1236

238)    Pettorruso M, Martinotti G, Montemitro C, De Risio L, Spagnolo PA, Gallimberti L, Fanella F, Bonci A, Di Giannantonio M; Brainswitch Study Group. Multiple Sessions of High-Frequency Repetitive Transcranial Magnetic Stimulation as a Potential Treatment for Gambling Addiction: A 3-Month, Feasibility Study. Eur Addict Res. 2020;26(1):52-56

239)    Pettorruso M, di Giannantonio M, De Risio L, Martinotti G, Koob GF. A Light in the Darkness: Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat the Hedonic Dysregulation of Addiction. J Addict Med. 2019 Nov 12

240)    Miuli A, Spano MC, Lorusso M, Sociali A, Pettorruso M, Di Muzio A, Martinotti G, di Giannantonio M, Martinotti G, Di Muzio A. Transcranial direct current stimulation for Phantom Limb Pain circuitopathy: Efficacy and safety in a patient with a cardiac defibrillator. Clin Neurophysiol. 2020 Jan;131(1):345-346

241)    Corkery JM, Schifano F, Martinotti G. How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances. Br J Clin Pharmacol. 2019 Nov 26

242)    De Berardis D, Vellante F, Fornaro M, Anastasia A, Olivieri L, Rapini G, Serroni N, Orsolini L, Valchera A, Carano A, Tomasetti C, Varasano PA, Pressanti GL, Bustini M, Pompili M, Serafini G, Perna G, Martinotti G, Di Giannantonio M. Alexithymia, suicide ideation, affective temperaments and homocysteine levels in drug naïve patients with post-traumatic stress disorder: an exploratory study in the everyday 'real world' clinical practice. Int J Psychiatry Clin Pract. 2019 Dec 12:1-5

243)    Pettorruso M, Martinotti G, Montemitro C, Miuli A, Spano MC, Lorusso M, Vellante F, di Giannantonio M.Craving and Other Transdiagnostic Dimensions in Addiction: Toward Personalized Neuromodulation Treatments. J ECT. 2020 Jan 6

244)    Calabrò M, Mandelli L, Crisafulli C, Porcelli S, Albani D, Politis A, Papadimitriou GN, Di Nicola M, Janiri L, Colombo R, Martinotti G, Bellomo A, Vieta E, Bonassi S, Frustaci A, Ducci G, Landi S, Boccia S, Serretti A. Correction to: Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer's disease. Mol Biol Rep. 2020 Jan 22

245)    Spagnolo PA, Montemitro C, Pettorruso M, Martinotti G, Di Giannantonio M. Better Together? Coupling Pharmacotherapies and Cognitive Interventions With Non-invasive Brain Stimulation for the Treatment of Addictive Disorders. Front Neurosci. 2020 Jan 10;13:1385

246)    De Berardis D, Tomasetti C, Pompili M, Serafini G, Vellante F, Fornaro M, Valchera A, Perna G, Volpe U, Martinotti G, Fraticelli S, Di Giannantonio M, Kim YK, Orsolini L. 'That's the Esketamine, Baby, there's Nothing You Can Do about It!' An Update on Glutamatergic System in Suicidal Depression. Curr Top Med Chem. 2020 Jan 30

247)    De Berardis D, Vellante F, Fornaro M, Orsolini L, Valchera A, Baroni G, Kim YK, Martinotti G, Di Giannantonio M. Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: a case report. Int Clin Psychopharmacol. 2020 Mar;35(2):113-118

248)    Vismara M, Caricasole V, Starcevic V, Cinosi E, Dell'Osso B, Martinotti G, Fineberg NA. Is cyberchondria a new transdiagnostic digital compulsive syndrome? A systematic review of the evidence. Compr Psychiatry. 2020 May;99:152167. 

249)    De Berardis D, Fornaro M, Anastasia A, Vellante F, Olivieri L, Rapini G.,Serroni N, Orsolini L, Valchera A, Carano A, Tomasetti C, Ventriglio A, Bustini M, Pompili M, Serafini G, Perna G, Iasevoli F, Martinotti G, Di Giannantonio M. Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a "real-world" chart review study. Braz J Psychiatry. 2020;42(3):317-321. 

250)    Picardi A, Pallagrosi M, Fonzi L, Martinotti G, Caroppo E, Meldolesi GN, Di Gennaro G, De Risi M, Biondi M. Attachment in Patients with Bipolar and Unipolar Depression: A Comparison with Clinical and Non-clinical Controls. Clin Pract Epidemiol Ment Health. 2019 Dec 31;15:143-152. 

251)    Orsolini L, Latini R, Pompili M, Serafini G, Volpe U, Vellante F, Fornaro M, Valchera A, Tomasetti C, Fraticelli S, Alessandrini M, La Rovere R, Trotta S, Martinotti G, Di Giannantonio M, De Berardis D. Understanding the Complex of Suicide in Depression: from Research to Clinics. Psychiatry Investig. 2020 Mar;17(3):207-221. 

252)    Miuli A, Pettorruso M, Romanelli E, Stigliano G, Di Giuda D, De-Giorgio F, Martinotti G, di Giannantonio M. Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis. Front Psychiatry. 2020 Apr 15;11:275. 

253)    Bartoli F, Ostuzzi G, Crocamo C, Corbo M, D'Agostino A, Martinotti G, Ostinelli EG, Tabacchi T, Barbui C, Carrà G; STAR Network Depot Investigators*. Clinical correlates of paliperidone palmitate and aripiprazole monohydrate prescription for subjects with schizophrenia-spectrum disorders: findings from the STAR Network Depot Study. Int Clin Psychopharmacol. 2020 Jul;35(4):214-220.

254)    Király O, Potenza MN, Stein DJ, King DL, Hodgins DC, Saunders JB, Griffiths MD, Gjoneska B, Billieux J, Brand M, Abbott MW, Chamberlain SR, Corazza O, Burkauskas J, Sales CMD, Montag C, Lochner C, Grünblatt E, Wegmann E, Martinotti G, Lee HK, Rumpf HJ, Castro-Calvo J, Rahimi-Movaghar A, Higuchi S, Menchon JM, Zohar J, Pellegrini L, Walitza S, Fineberg NA, Demetrovics Z. Preventing problematic internet use during the COVID-19 pandemic: Consensus guidance. Compr Psychiatry. 2020 Jul;100:152180. 

255)    Pettorruso M, Valle S, Cavic E, Martinotti G, di Giannantonio M, Grant JE. Problematic Internet use (PIU), personality profiles and emotion dysregulation in a cohort of young adults: trajectories from risky behaviors to addiction. Psychiatry Res. 2020 Jul;289:113036. 2020 May 16. 

256)    Calluso C, Pettorruso M, Tosoni A, Carenti ML, Cannito L, Martinotti G, di Giannantonio M, Committeri G. Cognitive dynamics of intertemporal choice in gambling disorder. Addict Behav. 2020 Oct;109:106463. 

257)    Costantini M, Salone A, Martinotti G, Fiori F, Fotia F, Di Giannantonio M, Ferri F. Body representations and basic symptoms in schizophrenia. Schizophr Res. 2020 Aug;222:267-273. doi: 10.1016/j.schres.2020.05.038. Epub 2020 May 24.

258)    Vellante F, Ferri F, Baroni G, Croce P, Migliorati D, Pettoruso M, De Berardis D, Martinotti G, Zappasodi F, Giannantonio MD. Euthymic bipolar disorder patients and EEG microstates: a neural signature of their abnormal self experience? J Affect Disord. 2020 Jul 1;272:326-334. 

259)    Martinotti G, De Risio L, Vannini C, Schifano F, Pettorruso M, Di Giannantonio M. Substance-related exogenous psychosis: a postmodern syndrome. CNS Spectr. 2020 Jun 25:1-8. 

260)    Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V. International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder. Eur Addict Res. 2020;26(4-5):223-232.

261)    Ostuzzi G, Gastaldon C, Barbato A, D'Avanzo B, Tettamanti M, Monti I, Aguglia A, Aguglia E, Alessi MC, Amore M, Bartoli F, Biondi M, Bortolaso P, Callegari C, Carrà G, Caruso R, Cavallotti S, Crocamo C, D'Agostino A, De Fazio P, Di Natale C, Giusti L, Grassi L, Martinotti G, Nosé M, Papola D, Purgato M, Rodolico A, Roncone R, Tarsitani L, Turrini G, Zanini E, Amaddeo F, Ruggeri M, Barbui C. Tolerability and efficacy of vortioxetine versus SSRIs in elderly with major depression. Study protocol of the VESPA study: a pragmatic, multicentre, open-label, parallel-group, superiority, randomized trial. Trials. 2020 Aug 3;21(1):695. 

262)    Miuli A, Stigliano G, Lalli A, Coladonato M, D'Angelo L, Esposito F, Cappello C, Pettorruso M, Martinotti G, Schifano F, Di Giannantonio M. "Purple Drank" (Codeine and Promethazine Cough Syrup): A Systematic Review of a Social Phenomenon with Medical Implications. J Psychoactive Drugs. 2020 Nov-Dec;52(5):453-462. 

263)    Pettorruso M, d'Andrea G, Martinotti G, Cocciolillo F, Miuli A, Di Muzio I, Collevecchio R, Verrastro V, De-Giorgio F, Janiri L, di Giannantonio M, Di Giuda D, Camardese G. Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates. Brain Sci. 2020 Aug5;10(8):519. 

264)    Martinotti G, Barlati S, Prestia D, Palumbo C, Giordani M, Cuomo A, Miuli A, Paladini C, Amore M, Bondi E, Vita A, Fagiolini A, Di Giannantonio M. Psychomotor agitation and hyperactive delirium in COVID-19 patients treated with aripiprazole 9.75 mg/1.3 ml immediate release. Psychopharmacology (Berl). 2020,Nov;237(11):3497-3501. 

265)     Di Carlo F, Sociali A, Picutti E, Pettorruso M, Vellante F, Verrastro V, Martinotti G, di Giannantonio M. Telepsychiatry and other cutting-edge technologies in COVID-19 pandemic: Bridging the distance in mental health assistance. Int J Clin Pract. 2021 Jan;75(1):e13716. 

266)    Martinotti G, Vannini C, Di Natale C, Sociali A, Stigliano G, Santacroce R, di Giannantonio M. Hikikomori: psychopathology and differential diagnosis of a condition with epidemic diffusion. Int J Psychiatry Clin Pract. 2020 Sep 28:1-8. 

267)    Pettorruso M, Miuli A, Di Natale C, Montemitro C, Zoratto F, De Risio L, d'Andrea G, Dannon PN, Martinotti G, di Giannantonio M. Non-invasive brain stimulation targets and approaches to modulate gambling-related decisions: A systematic review. Addict Behav. 2021 Jan;112:106657. 

268)    Pettorruso M, Zoratto F, Miuli A, De Risio L, Santorelli M, Pierotti A, Martinotti G, Adriani W, di Giannantonio M. Exploring dopaminergic transmission in gambling addiction: A systematic translational review. Neurosci Biobehav Rev. 2020 Dec;119:481-511. 

269)    Martinotti G, Pettorruso M, De Berardis D, Dell'Osso B, Di Sciascio G, Fiorillo A, Sani G, Albert U. Utilizzo clinico del litio e nuova formulazione a rilascio prolungato: risultati di una survey su psichiatri italiani [Clinical use of lithium and new retard formulation: results of a survey on Italian psychiatrists]. Riv Psichiatr. 2020 Sep-Oct;55(5):269-280. Italian.
.
270)    Martinotti G, Alessi MC, Di Natale C, Sociali A, Ceci F, Lucidi L, Picutti E, Di Carlo F, Corbo M, Vellante F, Fiori F, Tourjansky G, Catalano G, Carenti ML, Incerti CC, Bartoletti L, Barlati S, Romeo VM, Verrastro V, De Giorgio F, Valchera A, Sepede G, Casella P, Pettorruso M, di Giannantonio M. Psychopathological Burden and Quality of Life in Substance Users During the COVID-19 Lockdown Period in Italy. Front Psychiatry. 2020 Sep 3;11:572245. 

271)    Martinotti G, Negri A, Schiavone S, Montemitro C, Vannini C, Baroni G, Pettorruso M, De Giorgio F, Giorgetti R, Verrastro V, Trabace L, Garcia A, Castro I, Iglesias Lopez J, Merino Del Villar C, Schifano F, di Giannantonio M. Club Drugs: Psychotropic Effects and Psychopathological Characteristics of a Sample of Inpatients. Front Psychiatry. 2020 Aug 31;11:879.
.
272)    Vita A, Barlati S, Deste G, Rocca P, Rossi A, Bertolino A, Aguglia E, Amore M, Bellomo A, Biondi M, Carpiniello B, Collantoni E, Cuomo A, D'Ambrosio E, Dell' Osso L, di Giannantonio M, Giordano GM, Marchesi C, Monteleone P, Montemagni C, Oldani L, Pompili M, Roncone R, Rossi R, Siracusano A, Zeppegno P, Nibbio G, Galderisi S, Maj M; Italian Network for Research on Psychoses. The influence of autistic symptoms on social and non-social cognition and on real- life functioning in people with schizophrenia: Evidence from the Italian Network for Research on Psychoses multicenter study. Eur Psychiatry. 2020 Nov 10;63(1):e98. 

273)    De Risio L, Borgi M, Pettorruso M, Miuli A, Ottomana AM, Sociali A, Martinotti G, Nicolò G, Macrì S, di Giannantonio M, Zoratto F. Recovering from depression with repetitive transcranial magnetic stimulation (rTMS): a systematic review and meta-analysis of preclinical studies. Transl Psychiatry. 2020 Nov 10;10(1):393. 

274)    D'Ardes D, Carrarini C, Russo M, Dono F, Speranza R, Digiovanni A,Martinotti G, Di Iorio A, Onofrj M, Cipollone F, Bonanni L. Low molecular weight heparin in COVID-19 patients prevents delirium and shortens hospitalization. Neurol Sci. 2020 Nov 13:1–4. 

275)    De Berardis D, Ventriglio A, Fornaro M, Vellante F, Martinotti G, Fraticelli S, Di Giannantonio M. Overcoming the Use of Mechanical Restraints in PsychiatA New Challenge in the Everyday Clinical Practice at the Time of COVID-19. J Clin Med. 2020 Nov 23;9(11):3774. 

276)    De Berardis D, Olivieri L, Rapini G, Serroni N, Fornaro M, Valchera A, Carano A, Vellante F, Bustini M, Serafini G, Pompili M, Ventriglio A, Perna G, Fraticelli S, Martinotti G, Di Giannantonio M. Religious Coping, Hopelessness and Suicide Ideation in Subjects with First-Episode Major Depression: An Exploratory Study in the Real World Clinical Practice. Brain Sci. 2020 Nov 27;10(12):912. 

277)    Stigliano G, Miuli A, Vizziello A, Altomare AI, Lalli A, Alessi MC, Sociali A, Rucco A, Vannini C, Martinotti G, di Giannantonio M. Use and knowledge of novel synthetic opioids: An Italian survey. J Ethn Subst Abuse. 2020 Dec 14:1-11. 

278)    di Giannantonio M, Negri A, Schiavone S, Vannini C, Pettorruso M, De-Giorgio F, Verrastro V, Trabace L, Corbo M, Gottardo R, Camuto C, Mazzarino M, Barra A, De Berardis D, Lopez JI, Del Villar CM, Schifano F, Martinotti G. Prescription Drug Misuse in "Clubbers" and Disco Goers in Ibiza. Front Psychiatry. 2020 Dec 5;11:592594. 

279)    Di Cosmo G, Costantini M, Ambrosini E, Salone A, Martinotti G, Corbo M, Di Giannantonio M, Ferri F. Body-environment integration: Temporal processing of tactile and auditory inputs along the schizophrenia continuum. J Psychiatr Res. 2021 Feb;134:208-214. 

280)    Pettorruso M, Testa G, Granero R, Martinotti G, d'Andrea G, di Giannantonio M, Fernández-Aranda F, Mena-Moreno T, Gómez-Peña M, Moragas L, Baenas I, Del Pino-Gutierrez A, Codina E, Valenciano-Mendoza E, Mora-Maltas B, Zoratto F, Valero-Solís S, Guillen-Guzmán E, Menchón JM, Jiménez-Murcia S. The transition time to gambling disorder: The roles that age, gambling preference and personality traits play. Addict Behav. 2021 May;116:106813. 

281)    Barbui C, Bertolini F, Bartoli F, Calandra C, Callegari C, Carrà G, D'Agostino A, Lucii C, Martinotti G, Mastromo D, Moretti D, Monzani E, Porcellana M, Prestia D, Ostuzzi G; STAR Network Investigators. Reasons forinitiating long-acting antipsychotics in psychiatric practice: findings from the STAR Network Depot Study. Ther Adv Psychopharmacol. 2020 Dec 22;10:2045125320978102. 

282)    Mucci A, Galderisi S, Gibertoni D, Rossi A, Rocca P, Bertolino A, Aguglia E, Amore M, Bellomo A, Biondi M, Blasi G, Brasso C, Bucci P, Carpiniello B, Cuomo
A, Dell'Osso L, Giordano GM, Marchesi C, Monteleone P, Niolu C, Oldani L, Pettorruso M, Pompili M, Roncone R, Rossi R, Tenconi E, Vita A, Zeppegno P, Maj
M; Italian Network for Research on Psychoses. Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses. JAMA Psychiatry. 2021 Feb 10. 

283)    Schifano F, Chiappini S, Miuli A, Corkery JM, Scherbaum N, Napoletano F, Arillotta D, Zangani C, Catalani V, Vento A, Pettorruso M, Martinotti G, di
Giannantonio M, Guirguis A. New psychoactive substances (NPS) and serotonin syndrome onset: A systematic review. Exp Neurol. 2021 Feb 8:113638. 

284)    Di Carlo F, Pettorruso M, Alessi MC, Picutti E, Collevecchio R, Migliara G, Baroni G, Gambi F, Cinosi E, Martinotti G, Grant JE, di Giannantonio M. Characterizing the building blocks of Problematic Use of the Internet (PUI): The role of obsessional impulses and impulsivity traits among Italian young adults. Compr Psychiatry. 2021 Feb 1;106:152225. 

285)    Chiappini S, Schifano F, Martinotti G, Strasser JC, Bonnet U, Scherbaum N. Opioid painkiller dependence in a sample of elderly medical inpatients. Psychogeriatrics. 2021 Feb 16. 

286)    Corbo M, Martinotti G, Aguglia A, Salvi V, Amerio A, Calò S, Fusar-Poli L, Serafini G, Signorelli M, Amore M, Mencacci C, Di Sciascio G, Biggio G, Aguglia
E, Di Giannantonio M. Long-acting second-generation and oral antipsychotics for substance use disorders and psychotic symptoms: Prescribing attitudes among
Italian psychiatrists. Perspect Psychiatr Care. 2021;57(4):1700-1706

287)    Dores AR, Carvalho IP, Burkauskas J, Simonato P, De Luca I, Mooney R, Ioannidis K, Gómez-Martínez MÁ, Demetrovics Z, Ábel KE, Szabo A, Fujiwara H,
Shibata M, Ventola ARM, Arroyo-Anlló EM, Santos-Labrador RM, Griskova-Bulanova I, Pranckeviciene A, Kobayashi K, Martinotti G, Fineberg NA, Barbosa F, Corazza
O. Exercise and Use of Enhancement Drugs at the Time of the COVID-19 Pandemic: A Multicultural Study on Coping Strategies During Self-Isolation and Related
Risks. Front Psychiatry. 2021 10;12:648501

288)    Bertolini F, Ostuzzi G, Pievani M, Aguglia A, Bartoli F, Bortolaso P, Callegari C, Caroleo M, Carrà G, Corbo M, D'Agostino A, De Fazio P, Magliocco F, Martinotti G, Ostinelli EG, Piccinelli MP, Tedeschi F, Barbui C; STAR Network Investigators. Comparing Long-Acting Antipsychotic Discontinuation Rates Under Ordinary Clinical Circumstances: A Survival Analysis from an Observational, Pragmatic Study. CNS Drugs. 2021;35(6):655-665

289)    Lucidi L, Pettorruso M, Vellante F, Di Carlo F, Ceci F, Santovito MC, Di Muzio I, Fornaro M, Ventriglio A, Tomasetti C, Valchera A, Gentile A, Kim YK, Martinotti G, Fraticelli S, Di Giannantonio M, De Berardis D. Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment. Int J Mol Sci. 2021 2;22(7):3723

290)    Martinotti G, Schiavone S, Negri A, Vannini C, Trabace L, De Berardis D, Pettorruso M, Sensi SL, Di Giannantonio M. Suicidal Behavior and Club Drugs in Young Adults. Brain Sci. 2021;11(4):490

291)    Chiappini S, Schifano F, Martinotti G. Editorial: Prescribing Psychotropics: Misuse, Abuse, Dependence, Withdrawal and Addiction. Front Psychiatry. 2021, 30;12:688434

292)    Schifano F, Chiappini S, Miuli A, Mosca A, Santovito MC, Corkery JM, Guirguis A, Pettorruso M, Di Giannantonio M, Martinotti G. Focus on Over-the-Counter Drugs' Misuse: A Systematic Review on Antihistamines, Cough Medicines, and Decongestants. Front Psychiatry. 2021, 7;12:657397

293)    De Berardis D, Vellante F, Pettorruso M, Lucidi L, Tambelli A, Di Muzio I, Gianfelice G, Ventriglio A, Fornaro M, Serafini G, Pompili M, Perna G, Fraticelli S, Martinotti G, di Giannantonio M. Suicide and Genetic Biomarkers: Toward Personalized Tailored-treatment with Lithium and Clozapine. Curr Pharm Des. 2021, 5;27(30):3293-3304

294)    De Berardis D, Vellante F, Olivieri L, Rapini G, De Lauretis I, Orsolini L, Valchera A, Carano A, Bustini M, De Persis S, Trotta S, Fornaro M, Ventriglio A, Martiadis V, Simione L, Pompili M, Serafini G, Di Nicola M, Alessandrini M, Martinotti G, Fraticelli S, di Giannantonio M. The effect of paliperidone palmitate long-acting injectable (PP-LAI) on "non-core" symptoms of schizophrenia: a retrospective, collaborative, multicenter study in the "real world" everyday clinical practice. Riv Psichiatr. 2021 ;56(3):143-148

295)    Martinotti G, Chiappini S, Pettorruso M, Mosca A, Miuli A, Di Carlo F, D'Andrea G, Collevecchio R, Di Muzio I, Sensi SL, Di Giannantonio M. Therapeutic Potentials of Ketamine and Esketamine in Obsessive-Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature. Brain Sci. 2021;11(7):856

296)    Chiappini S, Mosca A, Miuli A, Santovito MC, Orsolini L, Corkery JM, Guirguis A, Pettorruso M, Martinotti G, Di Giannantonio M, Schifano F. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature. Medicina (Kaunas). 2021;57(6):580

297)    Martinotti G, Merino Del Villar C, Garcia Cordoba A, Andrés Tubau L, Castro Sánchez I, Di Carlo F, Chiappini S, Pettorruso M, Schifano F, Di Giannantonio M. Club Drugs and Psychiatric Sequelae: An Issue of Vulnerability and Previous Psychiatric History. Int J Environ Res Public Health. 2021;18(13):6944

298)    De Berardis D, Gianfelice G, Fornaro M, Vellante F, Ventriglio A, Marini G, Pettorruso M, Martinotti G, Fraticelli S, Di Giannantonio M. A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences. Front Psychiatry. 2021;12:650671

299)    Montemitro C, D'Andrea G, Cesa F, Martinotti G, Pettorruso M, Di Giannantonio M, Muratori R, Tarricone I. Language proficiency and mental disorders among migrants: A systematic review. Eur Psychiatry. 2021;64(1):e49

300)    Martinotti G, Bonanni L, Barlati S, Miuli A, Sepede G, Prestia D, Trabucco A, Palumbo C, Massaro A, Olcese M, D'Ardes D, Cipollone F, Amore M, Bondi E, Russo M, Carrarini C, Onofrj M, Sensi SL, Vita A, di Giannantonio M. Delirium in COVID-19 patients: a multicentric observational study in Italy. Neurol Sci. 2021;42(10):3981-3988

301)    Onofrj M, Digiovanni A, Ajdinaj P, Russo M, Carrarini C, Di Giannantonio M, Martinotti G, Sensi SL. The factitious/malingering continuum and its burden on public health costs: a review and experience in an Italian neurology setting. Neurol Sci. 2021;42(10):4073-4083

302)    Özgen H, Spijkerman R, Noack M, Holtmann M, Schellekens ASA, van de Glind G, Banaschewski T, Barta C, Begeman A, Casas M, Crunelle CL, Daigre Blanco C, Dalsgaard S, Demetrovics Z, den Boer J, Dom G, Eapen V, Faraone SV, Franck J, González RA, Grau-López L, Groenman AP, Hemphälä M, Icick R, Johnson B, Kaess M, Kapitány-Fövény M, Kasinathan JG, Kaye SS, Kiefer F, Konstenius M, Levin FR, Luderer M, Martinotti G, Matthys FIA, Meszaros G, Moggi F, Munasur-Naidoo AP, Post M, Rabinovitz S, Ramos-Quiroga JA, Sala R, Shafi A, Slobodin O, Staal WG, Thomasius R, Truter I, van Kernebeek MW, Velez-Pastrana MC, Vollstädt-Klein S, Vorspan F, Young JT, Yule A, van den Brink W, Hendriks V. Internationale Konsenserklärung zu Screening, Diagnostik und Behandlung von Jugendlichen und Heranwachsenden mit Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung und gleichzeitigen Störungen durch Substanzgebrauch [International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]. Z Kinder Jugendpsychiatr Psychother. 2021;50(1):54-67

303)    Onofrj M, Di Iorio A, Carrarini C, Russo M, Franciotti R, Espay AJ, Boylan LS, Taylor JP, Di Giannantonio M, Martinotti G, Valente EM, Thomas A, Bonanni L, Delli Pizzi S, Dono F, Sensi S. Preexisting Bipolar Disorder Influences the Subsequent Phenotype of Parkinson's Disease. Mov Disord. 2021;36(12):2840-2852

304)    Miuli A, Sepede G, Stigliano G, Mosca A, Di Carlo F, d'Andrea G, Lalli A, Spano MC, Pettorruso M, Martinotti G, di Giannantonio M. Hypomanic/manic switch after transcranial magnetic stimulation in mood disorders: A systematic review and meta-analysis. World J Psychiatry. 2021;11(8):477-490

305)    Ricci V, Ceci F, Di Carlo F, Lalli A, Ciavoni L, Mosca A, Sepede G, Salone A, Quattrone D, Fraticelli S, Maina G, Martinotti G. Cannabis use disorder and dissociation: A report from a prospective first-episode psychosis study. Drug Alcohol Depend. 2021;229(Pt A):109118

306)    Berardis D, Fornaro M, Ventriglio A, Valchera A, Vellante F, Pettorruso M, Martinotti G, Fraticelli S, Giannantonio MD. Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case Reports. Clin Psychopharmacol Neurosci. 2021;19(4):780-785

307)    Gjoneska B, Potenza MN, Jones J, Corazza O, Hall N, Sales CMD, Grünblatt E, Martinotti G, Burkauskas J, Werling AM, Walitza S, Zohar J, Menchón JM, Király O, Chamberlain SR, Fineberg NA, Demetrovics Z. Problematic use of the internet during the COVID-19 pandemic: Good practices and mental health recommendations. Compr Psychiatry. 2022;112:152279

308)    Ullah I, Awan HA, Aamir A, Diwan MN, de Filippis R, Awan S, Irfan M, Fornaro M, Ventriglio A, Vellante F, Pettorruso M, Martinotti G, Di Giannantonio M, De Berardis D. Role and Perspectives of Inflammation and C-Reactive Protein (CRP) in Psychosis: An Economic and Widespread Tool for Assessing the Disease. Int J Mol Sci. 2021;22(23):13032

309)    Ricci V, Martinotti G, Ceci F, Chiappini S, Di Carlo F, Burkauskas J, Susini O, Luciani D, Quattrone D, De Berardis D, Pettorruso M, Maina G, Di Giannantonio M. Duration of Untreated Disorder and Cannabis Use: An Observational Study on a Cohort of Young Italian Patients Experiencing Psychotic Experiences and Dissociative Symptoms. Int J Environ Res Public Health. 2021;18(23):12632

310)    Mazza M, Caroppo E, De Berardis D, Marano G, Avallone C, Kotzalidis GD, Janiri D, Moccia L, Simonetti A, Conte E, Martinotti G, Janiri L, Sani G. Psychosis in Women: Time for Personalized Treatment. J Pers Med. 2021;11(12):1279

311)    Aguglia A, Fusar-Poli L, Amerio A, Placenti V, Concerto C, Martinotti G, Carrà G, Bartoli F, D'Agostino A, Serafini G, Amore M, Aguglia E, Ostuzzi G, Barbui C; STAR Network Investigators. The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study. Front Psychiatry. 2021;12:784366

312)    Miuli A, d'Andrea G, Pettorruso M, Mancusi G, Mosca A, Di Carlo F, Martinotti G, di Giannantonio M. From a cycle to a period: the potential role ofBDNF as plasticity and phase-specific biomarker in cocaine use disorder. Curr Neuropharmacol. 2022
313)    Dal Farra D, Valdesalici A, Zecchinato G, De Sandre A, Saccon D, Simonato P, Corazza O, Martinotti G, Smith AL, Solmi M. Knowledge and Use of Novel Psychoactive Substances in an Italian Sample with Substance Use Disorders. Int J Environ Res Public Health. 2022;19(2):915

314)    Martinotti G, Pettorruso M, Montemitro C, Spagnolo PA, Acuti Martellucci C, Di Carlo F, Fanella F, di Giannantonio M; Brainswitch Study Group. Repetitive transcranial magnetic stimulation in treatment-seeking subjects with cocaine use disorder: A randomized, double-blind, sham-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 2022;116:110513

315)    Bartoli F, Cavaleri D, Callovini T, Riboldi I, Crocamo C, D'Agostino A, Martinotti G, Bertolini F, Ostuzzi G, Barbui C, Carrà G; STAR Network Depot Investigators. Comparing 1-year effectiveness and acceptability of once-monthly paliperidone palmitate and aripiprazole monohydrate for schizophrenia spectrum disorders: Findings from the STAR Network Depot Study. Psychiatry Res. 2022;309:114405

316)    Cataldo I, Burkauskas J, Dores AR, Carvalho IP, Simonato P, De Luca I, Gómez-Martínez MÁ, Melero Ventola AR, Demetrovics Z, Szabo A, Ábel KE, Shibata M, Kobayashi K, Fujiwara H, Arroyo-Anlló EM, Martinotti G, Barbosa F, Griskova- Bulanova I, Pranckeviciene A, Bowden-Jones H, Esposito G, Corazza O. An international cross-sectional investigation on social media, fitspiration content exposure, and related risks during the COVID-19 self-isolation period. J Psychiatr Res. 2022;148:34-44

317)    Alessi MC, Martinotti G, De Berardis D, Sociali A, Di Natale C, Sepede G, Cheffo DPR, Monti L, Casella P, Pettorruso M, Sensi S, Di Giannantonio M. Craving variations in patients with substance use disorder and gambling during COVID-19 lockdown: The Italian experience. World J Clin Cases. 2022;10(3):882-890

318)    Awan S, Diwan MN, Aamir A, Allahuddin Z, Irfan M, Carano A, Vellante F, Ventriglio A, Fornaro M, Valchera A, Pettorruso M, Martinotti G, Di Giannantonio M, Ullah I, De Berardis D. Suicide in Healthcare Workers: Determinants, Challenges, and the Impact of COVID-19. Front Psychiatry. 2022;12:792925

319)    Dell' Osso B, Di Nicola M, Cipelli R, Peduto I, Pugliese AC, Signorelli MS, Ventriglio A, Martinotti G. Antidepressant Prescription for Major Depressive Disorder: Results from a Population-Based Study in Italy. Curr Neuropharmacol. 2022

320)    Chiappini S, Mosca A, Miuli A, Semeraro FM, Mancusi G, Santovito MC, Di Carlo F, Pettorruso M, Guirguis A, Corkery JM, Martinotti G, Schifano F, Di Giannantonio M. Misuse of Anticholinergic Medications: A Systematic Review. Biomedicines. 2022;10(2):355

321)    Grundmann O, Veltri CA, Morcos D, Knightes D 3rd, Smith KE, Singh D, Corazza O, Cinosi E, Martinotti G, Walsh Z, Swogger MT. Exploring the self-reported motivations of kratom (<i>Mitragyna speciosa</i> Korth.) use: a cross-sectional investigation. Am J Drug Alcohol Abuse. 2022 Jul 4;48(4):433-444

322)    Di Nicola M, Dell'Osso B, Peduto I, Cipelli R, Pugliese AC, Signorelli MS, Ventriglio A, Martinotti G. Adherence to, and persistence of, antidepressant therapy in patients with major depressive disorder: results from a population-based study in Italy. Curr Neuropharmacol. 2022 Apr 11

323)    Aguglia A, Fusar-Poli L, Natale A, Amerio A, Espa I, Villa V, Martinotti G, Carrà G, Bartoli F, D'Agostino A, Serafini G, Amore M, Aguglia E, Ostuzzi G, Barbui C. Factors Associated with Medication Adherence to Long-Acting Injectable Antipsychotics: Results from the STAR Network Depot Study. Pharmacopsychiatry. 2022 Nov;55(6):281-289. doi: 10.1055/a-1804-6211

324)    Ceci F, Di Carlo F, Burkauskas J, Salone A, De Luca I, Cicconcelli D, Giorgetti V, La Fratta I, Todaro A, Simonato P, Martinotti G, di Giannantonio M, Corazza O. Physical Activity and Exercise Addiction During the Covid-19 Pandemic in Italy. Int J Ment Health Addict. 2022 Apr 20:1-21

325)    Sociali A, Borgi M, Pettorruso M, Di Carlo F, Di Natale C, Tambelli A, Alessi MC, Ciavoni L, Mosca A, Miuli A, Sensi SL, Martinotti G, Zoratto F, Di Giannantonio M. What role for cognitive remediation in the treatment of depressive symptoms? A superiority and noninferiority meta-analysis for clinicians. Depress Anxiety. 2022 Jul;39(7):586-606

326)    Nadeem F, Malik NI, Atta M, Ullah I, Martinotti G, Pettorruso M, Vellante F, Di Giannantonio M, De Berardis D. Relationship between Health-Anxiety and Cyberchondria: Role of Metacognitive Beliefs. J Clin Med. 2022 May 5;11(9):2590

327)    Chiappini S, Vickers-Smith R, Guirguis A, Corkery JM, Martinotti G, Schifano F. A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases. Pharmaceuticals (Basel). 2022 May 1;15(5):565

328)    Caldirola D, Torti T, Cuniberti F, Daccò S, Alciati A, Schruers K, Martinott G, De Berardis D, Perna G. No Sex Differences in Self-Reported Childhood Maltreatment in Major Depressive and Bipolar Disorders: A Retrospective Study. Brain Sci. 2022 Jun 19;12(6):804

329)    Chiappini S, Vickers-Smith R, Guirguis A, Corkery JM, Martinotti G, Harris DR, Schifano F. Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FAERS). Pharmaceuticals (Basel). 2022 May 27;15(6):675

330)    Martinotti G, Chiappini S, Mosca A, Miuli A, Santovito MC, Pettorruso M, Skryabin V, Sensi SL, Giannantonio MD. Atypical Antipsychotic Drugs in Dual Disorders: Current Evidence for Clinical Practice. Curr Pharm Des. 2022;28(27):2241-2259

331)    D'Agostino A, Aguglia A, Barbui C, Bartoli F, Carrà G, Cavallotti S, Chirico M, Ostinelli EG, Zangani C, Martinotti G, Ostuzzi G; STAR Network Depot Investigators. Off-label long acting injectable antipsychotics in real-world clinical practice: a cross-sectional analysis of prescriptive patterns from the STAR Network DEPOT study. BMC Psychiatry. 2022 Jun 30;22(1):442

332)    Chiappini S, Ceci F, Mosca A, Carlo FD, Burkauskas J, Pettorruso M, Martinotti G, Guirguis A, Corkery JM, Scherbaum N, Schifano F, Giannantonio MD. Knowledge and use of over-the-counter drugs in Italy: an exploratory survey-based study in the general population. Curr Neuropharmacol. 2022 Jul 14

333)    Miuli A, Mancusi G, Pettorruso M, Di Carlo F, Clemente K, Di Meo I, D'Andrea A, Pernaci G, Di Crosta T, d'Andrea G, Bubbico G, Martinotti G, Giannantonio MD. Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder. Neurosci Lett. 2022 Aug 24;786:136805

334)    Fraticelli S, Caratelli G, De Berardis D, Ducci G, Pettorruso M, Martinotti G, Di Cesare G, di Giannantonio M. Gender differences in attention deficit hyperactivity disorder: an update of the current evidence. Riv Psichiatr. 2022 Jul-Aug;57(4):159-164

335)    Di Natale C, Lucidi L, Montemitro C, Pettorruso M, Collevecchio R, Di Capri L, Giampietro L, Aceto L, Martinotti G, Giannantonio MD. Gender Differences in the Psychopathology of Obesity: How Relevant Is the Role of Binge Eating Behaviors? Brain Sci. 2022 Jul 21;12(7):955

336)    Burkauskas J, Fineberg NA, Ioannidis K, Chamberlain SR, Bowden-Jones H, Griskova-Bulanova I, Pranckeviciene A, Dores AR, Carvalho IP, Barbosa F, Simonato P, De Luca I, Mooney R, Gómez-Martínez MÁ, Demetrovics Z, Ábel KE, Szabo A, Fujiwara H, Shibata M, Melero-Ventola AR, Arroyo-Anlló EM, Santos- Labrador RM, Kobayashi K, Di Carlo F, Monteiro C, Martinotti G, Corazza O. Online Behaviours during the COVID-19 Pandemic and Their Associations with Psychological Factors: An International Exploratory Study. Int J Environ Res Public Health. 2022 Jul 20;19(14):8823

337)    Corkery JM, Guirguis A, Chiappini S, Martinotti G, Schifano F. Alprazolam-related deaths in Scotland, 2004-2020. J Psychopharmacol. 2022 Sep;36(9):1020-1035

338)    Fineberg NA, Menchón JM, Hall N, Dell'Osso B, Brand M, Potenza MN, Chamberlain SR, Cirnigliaro G, Lochner C, Billieux J, Demetrovics Z, Rumpf HJ, Müller A, Castro-Calvo J, Hollander E, Burkauskas J, Grünblatt E, Walitza S, Corazza O, King DL, Stein DJ, Grant JE, Pallanti S, Bowden-Jones H, Ameringen MV, Ioannidis K, Carmi L, Goudriaan AE, Martinotti G, Sales CMD, Jones J, Gjoneska B, Király O, Benatti B, Vismara M, Pellegrini L, Conti D, Cataldo I, Riva GM, Yücel M, Flayelle M, Hall T, Griffiths M, Zohar J. Advances in problematic usage of the internet research - A narrative review by experts from the European network for problematic usage of the internet. Compr Psychiatry. 2022 Oct;118:152346

339)    Pompili M, Innamorati M, Erbuto D, Luciano M, Sampogna G, Abbate-Daga G, Barlati S, Carmassi C, Castellini G, De Fazio P, Di Lorenzo G, Di Nicola M, Ferrari S, Goracci A, Gramaglia C, Martinotti G, Nanni MG, Pasquini M, Pinna F, Poloni N, Serafini G, Signorelli M, Tortorella A, Ventriglio A, Volpe U, Fiorillo A. High depression symptomatology and mental pain characterize suicidal psychiatric patients. Eur Psychiatry. 2022 Aug 31;65(1):e54

340)    Corkery JM, Martinotti G, Schifano F. Contribution of drugs to drownings in Scotland, 1996-2020. Curr Neuropharmacol. 2022 Aug 30

341)    Di Carlo F, Alessi MC, Picutti E, Pettorruso M, Martinotti G, di Giannantonio M. Online 12-step groups during the Covid-19 pandemic: A patient's perspective. Emerg Trends Drugs Addict Health. 2022;2:100047

342)    Martinotti G, Vita A, Fagiolini A, Maina G, Bertolino A, Dell'Osso B, Siracusano A, Clerici M, Bellomo A, Sani G, d'Andrea G, Chiaie RD, Conca A, Barlati S, Di Lorenzo G, De Fazio P, De Filippis S, Nicolò G, Rosso G, Valchera A, Nucifora D, Di Mauro S, Bassetti R, Martiadis V, Olivola M, Belletti S, Andriola I, Di Nicola M, Pettorruso M, McIntyre RS, di Giannantonio M; REAL-ESK Study Group. Real-world experience of esketamine use to manage treatment-resistant depression: A multicentric study on safety and effectiveness (REAL-ESK study). J Affect Disord. 2022 Dec 15;319:646-654

343)    Chiappini S, Picutti E, Alessi MC, Di Carlo F, D'Andrea G, Miuli A, Pettorruso M, Martinotti G, di Giannantonio M. Efficacy of Noninvasive Brain Stimulation on Borderline Personality Disorder Core Symptoms: A Systematic Review. J Pers Disord. 2022 Oct;36(5):505-526

344)    d'Andrea G, Pettorruso M, D'Andrea A, Collevecchio R, Santovito MC, Miuli A, Di Carlo F, Sensi SL, Martinotti G, di Giannantonio M. Combining Dopamine Agonists With Accelerated Repetitive Transcranial Magnetic Stimulation: A Case of Successful Treatment of Resistant Depression. J ECT. 2022 Oct 1

345)    Mosca A, Chiappini S, Miuli A, Mancusi G, Santovito MC, Carlo FD, Pettorruso M, Corkery JM, Canessa C, Martinotti G, Giannantonio MD. Ibogaine/Noribogaine in the Treatment of Substance Use Disorders: a Systematic Review of the Current Literature. Curr Neuropharmacol. 2022 Oct 17

346)    Martinotti G, Festa GM, Ceci F, Di Muzio I, Callea A, Capparelli A, Bonifaci L, Chillemi E, Pepe M, Pettorruso M, Chiappini S, Di Nicola M, Janiri L. Evaluating Craving in Alcohol Use Disorder: Psychometric Characteristics of the Craving Typology Questionnaire-15 (CTQ-15). Alcohol Alcohol. 2022 Oct 25:agac051

347)    Shoib S, Chandradasa M, Nahidi M, Amanda TW, Khan S, Saeed F, Swed S, Mazza M, Di Nicola M, Martinotti G, Di Giannantonio M, Armiya'u AY, De Berardis D. Facebook and Suicidal Behaviour: User Experiences of Suicide Notes, Live-Streaming, Grieving and Preventive Strategies-A Scoping Review. Int J Environ Res Public Health. 2022 Oct 11;19(20):13001

348)    D'Urso G, Toscano E, Barone A, Palermo M, Dell'Osso B, Di Lorenzo G, Mantovani A, Martinotti G, Fornaro M, Iasevoli F, de Bartolomeis A. Transcranial direct current stimulation for bipolar depression: systematic reviews of clinical evidence and biological underpinnings. Prog Neuropsychopharmacol Biol Psychiatry. 2023 Mar 8;121:110672

349)    Fornaro M, Cattaneo CI, De Berardis D, Ressico FV, Martinotti G, Vieta E. Antidepressant discontinuation syndrome: A state-of-the-art clinical review. Eur Neuropsychopharmacol. 2022 Nov 4;66:1-10.

350)    Schifano N, Chiappini S, Mosca A, Miuli A, Santovito MC, Pettorruso M, Capogrosso P, Dehò F, Martinotti G, Schifano F. Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels' Decline: A Narrative Review. Brain Sci. 2022 Nov 19;12(11):1582

351)    Bartoli F, Callovini T, Cavaleri D, Crocamo C, Riboldi I, Aguglia A, De Fazio P, Martinotti G, D'Agostino A, Ostuzzi G, Barbui C, Carrà G; STAR Network Depot Investigators. Effect of long-acting injectable antipsychotics on 1-year hospitalization in bipolar disorder: a mirror-image study. Eur Arch Psychiatry Clin Neurosci. 2022 Nov 27

352)    Ricci V, Martinotti G, De Berardis D, Maina G. Lurasidone use in Cannabis-Induced Psychosis: A Novel Therapeutic Strategy and Clinical Considerations in Four Cases Report. Int J Environ Res Public Health. 2022 Nov 30;19(23):16057

353)    Sampogna G, Janiri D, Albert U, Caraci F, Martinotti G, Serafini G, Tortorella A, Zuddas A, Sani G, Fiorillo A. Why lithium should be used in patients with bipolar disorder? A scoping review and an expert opinion paper. Expert Rev Neurother. 2022 Dec 23

354)    Cuomo A, Aguglia E, Biagini S, Carano A, Clerici M, D'Agostino A, De Filippis S, De Giorgi S, Goracci A, Libri C, Lombardi F, Lupi M, Maina G, Martinotti G, Nigro P, Pettorruso M, Ricci V, Rossi E, Russo F, Fagiolini A; Italian Clinical Psychopharmacology Working Group. Two-Injection Start Regimen of Long-Acting Aripiprazole in 133 Patients With Schizophrenia. J Clin Psychopharmacol. 2023Jan-Feb 01;43(1):35-38. 

355)    De Berardis D, Fornaro M, Martinotti G, Di Giannantonio M. Commentary: What Happens to Subjects with Impaired Emotion Recognition Skills, and What To Do? Alpha Psychiatry. 2022 Nov 1;23(6):274-275. doi: 10.5152/alphapsychiatry.2022.14112022. 

356)    Rocca P, Rucci P, Montemagni C, Rossi A, Bertolino A, Aguglia E, Altamura CA, Amore M, Andriola I, Bellomo A, Brasso C, Carpiniello B, Del Favero E, Dell'Osso L, Di Fabio F, Fabrazzo M, Fagiolini A, Giordano GM, Marchesi C, Martinotti G, Monteleone P, Pompili M, Roncone R, Rossi R, Siracusano A, Tenconi E, Vita A, Zeppegno P, Galderisi S, Maj M; Italian Network for Research on Psychoses. Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses. Eur Psychiatry. 2023 Jan 11;66(1):e10

357)    Grundmann O, Veltri CA, Morcos S, Smith KE, Singh D, Corazza O, Cinosi E, Martinotti G, Walsh Z, Swogger MT. Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey. Exp Clin Psychopharmacol. 2023 Jan 12

358)    Martinotti G, Dell'Osso B, Di Lorenzo G, Maina G, Bertolino A, Clerici M, Barlati S, Rosso G, Di Nicola M, Marcatili M, d'Andrea G, Cavallotto C,Chiappini S, De Filippis S, Nicolò G, De Fazio P, Andriola I, Zanardi R, Nucifora D, Di Mauro S, Bassetti R, Pettorruso M, McIntyre RS, Sensi SL, di Giannantonio M, Vita A; REAL-ESK Study Group. Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression. Bipolar Disord. 2023 May;25(3):233-244. 

359)    Skryabin VY, Martinotti G, Franck J, Zastrozhin MS. Acute Alcoholic Hallucinosis: A Review. Psychopathology. 2023 Jan 19:1-8

360)    Ricci V, Ceci F, Di Carlo F, Di Muzio I, Ciavoni L, Santangelo M, Di Salvo G, Pettorruso M, Martinotti G, Maina G. First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness. Psychiatry Res. 2023 Feb;320:115053

361)    Pettorruso M, Di Carlo F, Romeo VM, Jimenez-Murcia S, Grant JE, Martinotti G, Di Giannantonio M. The pharmacological management of gambling disorder: if, when, and how. Expert Opin Pharmacother. 2023 Mar;24(4):419-423

362)    Janiri D, Sampogna G, Albert U, Caraci F, Martinotti G, Serafini G, Tortorella A, Zuddas A, Fiorillo A, Sani G. Lithium use in childhood and adolescence, peripartum, and old age: an umbrella review. Int J Bipolar Disord. 2023 Feb 12;11(1):8

363)    d'Andrea G, Pettorruso M, Lorenzo GD, Mancusi G, McIntyre RS, Martinotti G. Rethinking ketamine and esketamine action: Are they antidepressants with mood- stabilizing properties? Eur Neuropsychopharmacol. 2023 May;70:49-55

364)    Ricci V, De Berardis D, Maina G, Martinotti G. Internet Gaming Disorders and Early Onset Psychosis in Young People: A Case Study and Clinical Observations. Int J Environ Res Public Health. 2023 Feb 22;20(5):3920

365)    Caldirola D, Daccò S, Grassi M, Alciati A, Sbabo WM, De Donatis D, Martinotti G, De Berardis D, Perna G. Cardiorespiratory Assessments in Panic Disorder Facilitated by Wearable Devices: A Systematic Review and Brief Comparison of the Wearable Zephyr BioPatch with the Quark-b2 Stationary Testing System. Brain Sci. 2023 Mar 16;13(3):502

366)    Mazza M, Kotzalidis GD, Marano G, De Berardis D, Martinotti G, Romagnoli E, Biondi-Zoccai G, Abbate A, Sani G. Lorcaserin: Worthy of Further Insights? Results from Recent Research. CNS Neurol Disord Drug Targets. 2023 Mar 30

367)    Onofrj M, Ajdinaj P, Digiovanni A, Malek N, Martinotti G, Ferro FM, Russo M, Thomas A, Sensi SL. Functional Neurologic Disorders, disorders to be managed by neurologists, or are neurologists wandering in a dangerous field with inadequate resources? Front Psychiatry. 2023 Mar 17;14:1120981

368)    Ostuzzi G, Tedeschi F, Bertolini F, Cotugno C, Aguglia A, Bartoli F, Carrà G, D'Agostino A, Martinotti G, Barbui C, Gastaldon C, Papola D. Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study. Schizophrenia (Heidelb). 2023 Apr 17;9(1):23

369)    d'Andrea G, Mancusi G, Santovito MC, Marrangone C, Martino F, Santorelli M, Miuli A, Di Carlo F, Signorelli MS, Clerici M, Pettorruso M, Martinotti G. Investigating the Role of Maintenance TMS Protocols for Major DepressionSystematic Review and Future Perspectives for Personalized Interventions. J Pers Med. 2023 Apr 21;13(4):697

370)    Chiappini S, d'Andrea G, De Filippis S, Di Nicola M, Andriola I, Bassetti R, Barlati S, Pettorruso M, Sensi S, Clerici M, Dell'Osso B, Vita A, Martinotti G. Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study. Eur Neuropsychopharmacol. 2023 May 4;74:15-21

371)    Chiappini S, Schifano F, Martinotti G. Editorial: Prescribing psychotropics: Misuse, abuse, dependence, withdrawal and addiction, Volume II. Front Psychiatry. 2022 Oct 18;13:1053896

372)    Di Carlo F, Verrastro V, Alessi MC, Sociali A, Altomare AI, Di Natale C, Stigliano G, Miuli A, Lalli A, Di Petta G, Chiappini S, Pettorruso M, Bowden-Jones H, Griffiths MD, Martinotti G. High-Risk Gaming Is Associated with Frequent Substance Use: An Exploratory Survey among Young Adults. Eur Addict Res. 2023;29(4):241-252

373)    De Berardis D, Martinotti G. Rethinking 'Innovation' in Psychiatry with Older and Newer Treatments: From Bench to Benchside. Curr Neuropharmacol. 2023;21(11):2176-2177

374)    De Berardis D, Ricci V, Mazza M, Ullah I, Amerio A, Martinotti G. Commentary: Increased Risk of Cardiovascular Disease in Restless Legs SyndromePatients: A Call to Action. Alpha Psychiatry. 2023 May 1;24(3):100-101

375)    Bucci P, Mucci A, Giordano GM, Caporusso E, Giuliani L, Gibertoni D, Rossi A, Rocca P, Bertolino A, Galderisi S; on the behalf of the Italian Network for Research on Psychoses. Insight in cognitive impairment assessed with the Cognitive Assessment Interview in a large sample of patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2023 Jun 28

376)    Pettorruso M, d'Andrea G, Di Carlo F, De Risio L, Zoratto F, Miuli A, Benatti B, Vismara M, Pompili E, Nicolò G, Niolu C, Siracusano A, Sensi SS, Dell'Osso B, Di Lorenzo G, Martinotti G; ReModula Study Group. Comparing fast-acting interventions for treatment-resistant depression: An explorative study of accelerated HF-rTMS versus intranasal esketamine. Brain Stimul. 2023 Jul-Aug;16(4):1041-1043

377)    d'Andrea G, Chiappini S, McIntyre RS, Stefanelli G, Carullo R, Andriola I, Zanardi R, Martiadis V, Sensi SL, Sani G, Clerici M, Di Lorenzo G, Vita A, Pettorruso M, Martinotti G. Investigating the Effectiveness and Tolerability of Intranasal Esketamine Among Older Adults With Treatment-Resistant Depression (TRD): A Post-hoc Analysis from the REAL-ESK Study Group. Am J Geriatr Psychiatry. 2023 Jul 8: S1064 7481(23)00351-2

378)    Chiappini S, Vickers-Smith R, Harris D, Papanti Pelletier GD, Corkery JM, Guirguis A, Martinotti G, Sensi SL, Schifano F. Is There a Risk for Semaglutide Misuse? Focus on the Food and Drug Administration's FDA Adverse Events Reporting System (FAERS) Pharmacovigilance Dataset. Pharmaceuticals (Basel). 2023 Jul 11;16(7):994

379)    Miuli A, Pettorruso M, Stefanelli G, Giovannetti G, Cavallotto C, Susini O, Pasino A, Bubbico G, De Risio L, Petta GD, Sensi SL, D'Antonio F, Martinotti G. Beyond the efficacy of transcranial magnetic stimulation in peripartum depression: A systematic review exploring perinatal safety for newborns. Psychiatry Res. 2023 Aug;326:115251

380)    Mosca A, Miuli A, Mancusi G, Chiappini S, Stigliano G, De Pasquale A, Di Petta G, Bubbico G, Pasino A, Pettorruso M, Martinotti G. To bridge or not to bridge: Moral Judgement in Cocaine Use Disorders, a case-control study on human morality. Soc Neurosci. 2023 Aug 18:1-11

381)    Selvaggi P, Fazio L, Toro VD, Mucci A, Rocca P, Martinotti G, Cascino G, Siracusano A, Zeppegno P, Pergola G, Bertolino A, Blasi G, Galderisi S; Italian Network for Research on Psychosis. Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia. Schizophr Res. 2023 Aug 24;260:76-84

382)    Ricci V, de Berardis D, Martinotti G, Maina G. Neurotrophic Factors In Cannabis-Induced Psychosis: An Update. Curr Top Med Chem. 2023 Aug 29

383)    Chiappini S, Di Carlo F, Mosca A, d'Andrea G, Di Paolo M, Lorenzini C, Lupica MG, Sampogna G, Pettorruso M, Fiorillo A, Martinotti G. Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study. Neuropsychiatr Dis Treat. 2023 Aug 30;19:1887-1897

384)    Sampogna G, Caraci F, Carmassi C, Dell'Osso B, Ferrari S, Martinotti G, Sani G, Serafini G, Signorelli MS, Fiorillo A. Efficacy and tolerability of desvenlafaxine in the real-world treatment of patients with major depression: a narrative review and an expert opinion paper. Expert Opin Pharmacother. 2023 Sep-Dec;24(14):1511-1525

385)    Di Nicola M, Pepe M, Montanari S, Bonomo L, Casile F, Panaccione I, Franza R, Chieffo D, Martinotti G, Addolorato G, Janiri L, Sani G. Predictors of polysubstance use in patients with severe alcohol use disorder: the role of reward craving. J Psychiatr Res. 2023 Sep;165:290-297

386)    Pettorruso M, Guidotti R, d'Andrea G, De Risio L, D'Andrea A, Chiappini S, Carullo R, Barlati S, Zanardi R, Rosso G, De Filippis S, Di Nicola M, Andriola I, Marcatili M, Nicolò G, Martiadis V, Bassetti R, Nucifora D, De Fazio P, Rosenblat JD, Clerici M, Maria Dell'Osso B, Vita A, Marzetti L, Sensi SL, Di Lorenzo G, McIntyre RS, Martinotti G; REAL-ESK Study Group. Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING). Psychiatry Res. 2023 Sep;327:115378

387)    Dell'Osso B, Martinotti G. Exploring the potential of Esketamine in the treatment of bipolar depression. Eur Neuropsychopharmacol. 2023 Sep 1;77:21-23

388)    d'Andrea G, Pettorruso M, Rhee TG, Di Lorenzo G, McIntyre RS, Martinotti G. Exploring the potential of a bridge therapy: Synergistic approach integrating intravenous ketamine and intranasal esketamine for treatment-resistant depression. Acta Psychiatr Scand. 2023 Oct;148(4):385-387

389)    Argote M, Sescousse G, Brunelin J, Baudin G, Schaub MP, Rabin R, Schnell T, Ringen PA, Andreassen OA, Addington JM, Brambilla P, Delvecchio G, Bechdolf A, Wobrock T, Schneider-Axmann T, Herzig D, Mohr C, Vila-Badia R, Rodie JU, Mallet J, Ricci V, Martinotti G, Knížková K, Rodriguez M, Cookey J, Tibbo P, Scheffler F, Asmal L, Garcia-Rizo C, Amoretti S, Huber C, Thibeau H, Kline E, Fakra E, Jardri R, Nourredine M, Rolland B. Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals. EClinicalMedicine. 2023 Sep 8;64:102199

390)    De Risio L, Pettorruso M, Collevecchio R, Collacchi B, Boffa M, Santorelli M, Clerici M, Martinotti G, Zoratto F, Borgi M. Staying connected: An umbrella review of meta-analyses on the push-and-pull of social connection in depression. J Affect Disord. 2024 Jan 15;345:358-368. 

391)    Chiappini S, Papanti Pelletier GD, Vickers-Smith R, Corkery JM, Guirguis A, Martinotti G, Schifano F. Exploring the nexus of binge eating disorder (BED), New Psychoactive Substances (NPS), and misuse of pharmaceuticals: charting a path forward. Expert Opin Pharmacother. 2023 Sep-Dec;24(18):1915-1918. 

392)    Delli Pizzi S, Chiacchiaretta P, Sestieri C, Ferretti A, Tullo MG, Della Penna S, Martinotti G, Onofrj M, Roseman L, Timmermann C, Nutt DJ, Carhart-Harris RL, Sensi SL. LSD-induced changes in the functional connectivity of distinct thalamic nuclei. Neuroimage. 2023 Dec 1;283:120414. 

393)    Wu J, Kwan AT, Rhee TG, Ho R, d'Andrea G, Martinotti G, Teopiz KM, Ceban F, McIntyre RS. A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia. Expert Rev Clin Pharmacol. 2023 Jul-Dec;16(11):1085-1092. 

394)    Vita A, Barlati S, Deste G, Rossi A, Rocca P, Bertolino A, Aguglia E, Altamura CA, Amore M, Bellomo A, Bucci P, Carpiniello B, Cuomo A, Dell'Osso L, Giuliani L, Marchesi C, Martinotti G, Monteleone P, Montemagni C, Nibbio G, Pasquini M, Pompili M, Rampino A, Roncone R, Rossi R, Siracusano A, Tenconi E, Zeppegno P, Galderisi S, Maj M; Italian Network for Research on Psychoses. Autistic symptoms in unaffected first-degree relatives of people with schizophrenia: results from the Italian Network for Research on Psychoses multicenter study. Eur Psychiatry. 2023 Oct 23;66(1):e85. 

395)    Rossi R, Reda F, Federico I, Jannini TB, Socci V, D'Aurizio G, Pettorruso M, Pacitti F, Rossi A, Martinotti G, Di Lorenzo G. The association between traumatic experiences and substance and behavioral addictions in late adolescence: A role for PTSD and cPTSD as potential mediators. J Psychiatr Res. 2023 Dec;168:82-90. 

396)    Ricci V, Maina G, Martinotti G. Dissociation and Temporality in Substance Abuse: A Clinical Phenomenological Overview. Psychopathology. 2023 Oct 30:1-10. 

397)    Ricci V, Cristofori E, Passarello E, Paggi A, Cavallo A, Ceci F, Martinotti G, De Berardis D, Maina G. CANNABIS USE AND SUICIDE IN NON-AFFECTIVE PSYCHOSIS: A MINI-REVIEW OF RECENT LITERATURE. Psychiatr Danub. 2023 Fall;35(3):307-319. d 

398)    Riaz K, Suneel S, Hamza Bin Abdul Malik M, Kashif T, Ullah I, Waris A, Di Nicola M, Mazza M, Sani G, Martinotti G, De Berardis D. MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence. Diseases. 2023 Nov 3;11(4):159. 

399)    Maina G, Adami M, Ascione G, Bondi E, De Berardis D, Delmonte D, Maffezzoli S, Martinotti G, Nivoli A, Ottavianelli E; Delphi Panel Collaboration Group; Fagiolini A. Nationwide consensus on the clinical management of treatment-resistant depression in Italy: a Delphi panel. Ann Gen Psychiatry. 2023 Nov 23;22(1):48. 

400)    Arillotta D, Floresta G, Guirguis A, Corkery JM, Catalani V, Martinotti G, Sensi SL, Schifano F. GLP-1 Receptor Agonists and Related Mental Health Issues; Insights from a Range of Social Media Platforms Using a Mixed-Methods Approach. Brain Sci. 2023 Oct 24;13(11):1503. 

401)    d'Andrea G, Pettorruso M, Di Lorenzo G, Rhee TG, Chiappini S, Carullo R, Barlati S, Zanardi R, Rosso G, Di Nicola M, Andriola I, Marcatili M, Clerici M, Dell'Osso BM, Sensi SL, Mansur RB, Rosenblat JD, Martinotti G, McIntyre RS. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data. J Affect Disord. 2024 Mar 1;348:314-322. 

402)    Di Carlo F, Vicinelli MC, Pettorruso M, De Risio L, Migliara G, Baccolini V, Trioni J, Grant JE, Dell'Osso B, Martinotti G. Connected minds in disconnected bodies: Exploring the role of interoceptive sensibility and alexithymia in problematic use of the internet. Compr Psychiatry. 2024 Feb;129:152446.

403)    Castellini G, Tarchi L, Cassioli E, Ricca V, Abbate Daga G, Aguglia A, Albert U, Atti A, Barlati S, Blasi G, Carmassi C, Carrà G, De Fazio P, De Panfilis C, Di Lorenzo G, Ferrari S, Goracci A, Gramaglia C, Luciano M, Martinotti G, Menchetti M, Menculini G, Nanni MG, Nivoli A, Pinna F, Pompili M, Rosso G, Sambataro F, Sampogna G, Sani G, Serafini G, Signorelli MS, Tosato S, Ventriglio A, Viganò C, Volpe U, Fiorillo A. The interplay between mentalization, personality traits and burnout in psychiatry training: Results from a large multicenter controlled study. Acta Psychiatr Scand. 2024 Mar;149(3):177-194. 

404)    Pettorruso M, Miuli A, Clemente K, Mancusi G, Migliara G, Di Carlo F, Pernaci G, Di Crosta T, Santorelli M, d'Andrea G, De Risio L, Ciavarella M, Baccolini V, Di Meo I, Cataldo I, Sensi SL, Martinotti G. Enhanced peripheral levels of BDNF and proBDNF: elucidating neurotrophin dynamics in cocaine use disorder. Mol Psychiatry. 2024 Jan 4. 

405)    Pettorruso M, Di Lorenzo G, De Risio L, Di Carlo F, d'Andrea G, Martinotti G. Addiction biotypes: a paradigm shift for future treatment strategies? Mol Psychiatry. 2024 Jan 19. 

406)    Martinotti G, Fornaro M, De Berardis D. Comorbidity in bipolar disorder and schizophrenia, volume III. Front Psychiatry. 2024 Jan 9;14:1356817. 

407)    Ricci V, Di Muzio I, Ceci F, Di Carlo F, Mancusi G, Piro T, Paggi A, Pettorruso M, Vellante F, De Berardis D, Martinotti G, Maina G. Aberrant salience in cannabis-induced psychosis: a comparative study. Front Psychiatry. 2024 Jan 8;14:1343884. 

408)   Ostuzzi G, Gastaldon C, Tettamanti M, Cartabia M, Monti I, Aguglia A, Aguglia E, Bartoli F, Callegari C, Canozzi A, Carbone EA, Carrà G, Caruso R, Cavallotti S, Chiappini S, Colasante F, Compri B, D'Agostino A, De Fazio P, de Filippis R, Gari M, Ielmini M, Ingrosso G, Mammarella S, Martinotti G, Rodolico A, Roncone R, Sterzi E, Tarsitani L, Tiberto E, Todini L, Amaddeo F, D'Avanzo B; VESPA Study Group; Barbato A, Barbui C. Tolerability of vortioxetine compared to selective serotonin reuptake inhibitors in older adults with major depressive disorder (VESPA): a randomised, assessor-blinded and statistician-blinded, multicentre, superiority trial. EClinicalMedicine. 2024